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1 ABSTRACT 
Gemcitabine is a well established anticancer compound, and is in use today against several types of 
cancers. Gemcitabine has a short half life. Formulations of gemcitabine containing liposomes could 
extend it's half life, thereby maybe improving its effectiveness.   Also, liposomes in the smaller size 
range have an advantage when it comes to treating cancer. They accumulate at the site of the tumor, 
and stay there for a longer time than it would have done in normal tissue(Massing and Fuxius 2000).  
Previous attempts to actively load gemcitabine into liposomes have used a pH gradient with acidic pH 
inside compared to more neutral pH on the outside of the liposomes, accomplished by an ammonium 
sulphate gradient. But this approach showed some difficulties; among other things that gemcitabine had 
a tendency to leak out in very short time. (Gravem 2006). 
In this thesis I have among other things investigated the possibility of loading gemcitabine into liposomes 
by precipitation. The hope was that this could give higher trapping efficiency and reduced leakage 
compared to the ammonium sulphate approach. 
Firstly, for comparable reasons and method development, an approach to load liposomes via an 
ammonium sulphate gradient was tried. Thought after encountering several problems the experiment 
was ended without any results indicating loading, most likely due to heavily diluted liposomes. 
Secondly I investigated if I could make gemcitabine precipitate. Firstly I tried a great range of different 
phosphate and sulphate salts, to test if any of them would cause a precipitation. Precipitation seemed to 
be independent of which salt used, but enhanced by factors such as high concentration of gemcitabine, 
alkaline conditions (pH ≥ 6), and low temperature. The two last conditions were the total opposites of 
loading via an ammonium sulphate gradient, and contained several contradictions as it meant that the 
outer pH had to be significantly lower to avoid precipitation and that a low temperature made it harder 
for gemcitabine to cross the membrane of the liposomes.  
An attempt to load gemcitabine into liposomes, using a pH 4 in the outer phase and pH 7 in the inner 
phase of the liposomes, with repeated cooling and freezing cycles, revealed poor loading. Thought 
optimizing conditions such as pHs, and time and temperatures in the cooling freezing cycles might 
enhance the loading a bit it is difficult to see this approach becoming a success. 
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2 ABBREVIATIONS 
AO Acredine Orange 
APD Ammonium phosphate (dibasic) 
CME Cellulose mixed ester 
DAC Dual asymmetric centrifugation 
dFdC Gemcitabine 
EPC-3 Hydrogenated egg Phosphatidyl Choline 
HPLC High Performance Liquid Chromatography 
MLVs Multi Lamellar Vesicles 
Mr relative molecular weight 
(The ratio of the mass of a molecule, compared to 
1/12 of the mass of 12C) 
PCS Photon Correlation Spectrometer 
PDP Potassium dihydrogen phosphate 
RPM rounds per minute 
SUVs Small Unilamellar Vesicles 
VPGs Vesicular Phospholipids Gels 
 
 
  9 
3 INTRODUCTION 
3.1 Liposomes 
Liposomes are small self assembling vesicles containing an inner aqueous compartment that is 
surrounded by a lipid bilayer of phospholipids, and often also cholesterol. Because of its properties, both 
having an aqueous compartment and a lipid bilayer makes it suitable for drug carriers for both 
hydrophilic and lipophilic drugs (see figure bellow) (Massing and Fuxius 2000).  
 
Figure 3.1. Illustration of how liposomes are suitable as drug carriers for both hydrophilic and lipophilic 
drugs. (taken with permission from (Massing and Fuxius 2000)) 
3.2 Vesicular phospholipids gels 
Vesicular phospholipids gels (VPGs),  are concentrated liposomal dispersions, with high lipid content, 
and the water content entrapped within the vesicles is about the same as the water content on the 
outside (Brandl, Drechsler et al. 1997). The morphology of VPGs were first described by (Brandl, 
Drechsler et al. 1997). When redispersing VPGs in water, they form conventional liposomes (Brandl, 
Drechsler et al. 1998).  
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3.3 Gemcitabine into liposomes 
3.3.1 Gemcitabine mechanism of action 
Gemcitabine (dFdC) is a nucleoside-analogue of the pyrimidine type. It's a prodrug that is converted 
intracellulraly to its active metabolite difluorodeoxycytidine di- and triphosphate (dFdCDP and 
dFdCTP). dFdCDP possess anti cancer activity by inhibiting ribonucleotide reductase, and thereby 
decreasing the deoxynucleotide pool available for DNA synthesis. dFdCCTP gets incorporated in DNA 
and results in DNA strand termination and apoptosis. (N.N. 2009a) 
3.3.2 Property’s of gemcitabine, and the advantage of a liposomal formulation 
As mentioned above gemcitabine is a prodrug, which is activated to its active metabolite intracellurlaly. 
Its half-life in the body is relatively short, only between 42 and 94 minutes, depending on gender and 
age (N.N. 2009c). As any drug entrapped inside a liposome vesicle would be protected against 
metabolic breakdown and elimination, liposomes could enhance the short half-life of gemcitabine. 
Liposomes also serve several other beneficial properties, among other things liposomes in the smaller 
size range (up to a diameter of 400-600 nm) will have enhanced permeability and retention effect at the 
site of the tumor (see figure bellow). This is because of the special characteristics this tissue holds that 
differs from that in normal healthy tissue; the blood vesicles in tumor sites are leakier due to their 
accelerated growth to enable rapid tumor growth, and the cells are often not as densely packed as cells 
in healthy tissue. In addition the lymphatic system is often less expressed in tumor tissue. (Massing and 




Figure 3.2. Illustration of gemcitabines enhanced permeability and retention effect in it tumor-tissue 
(taken with permission from (Massing and Fuxius 2000)) 
3.3.3 Previous attempts to load gemcitabine into liposome’s 
There has been made some attempts to make gemcitabine containing liposomes, though none of them 
has ever reached clinical trials. One problem with dFdC is that the small dFdC molecules has shown 
efflux very rapidly out of the vesicles (Brandl and Massing 2003). dFdC also induce hydrolytic 
degradation of phospatidylcholine. This degradation occurs especially at higher concentrations of 
gemcitabine, elevated temperatures, or extreme pHs. (Moog, Brandl et al. 2000). 
In an approach to avid the above problems and increase shelf life one approach entrapping dFdC 
passively into VPGs were carried out by (Brandl and Massing 2003). The loading efficiency was about 
35% (so solution also contained 65% non entrapped drug). Since the VPGs were not diluted until 
directly before use this gave a shelf life of >14 months. Testing of the formulation in mice showed 
promising results. It was never tested in clinical trials in humans. 
In an approach loading dFdC into liposomes actively by  (Gravem 2006), an ammonium sulphate 
gradient was used (mechanisms described further below). Loading efficiencies ranged from 3% to 28%. 
The liposomes showed pure stability, with 80% of dFdC-content leaking out within 24 hours. 
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3.4 Active loading 
3.4.1 Loading drugs using a transmembrane ammonium sulphate gradient 
Gemcitabine (pKa 3.58), and the model substance Acredine Orange (pKa 10.45), are weak bases(N.N. 
2005; Barenholz 2007). When the pH in a solution is lower then the pKa, more then 50% of the drug 









If we want to solve the equation with consideration on the amount of protonated base (BH+), the 










The idea with a transmembrane pH-gradient is that the neutral (not protonated) form of the drug has 
the ability to penetrate the liposome membrane, while the protonated form of the drug doesn't. So if 
the pH inside the liposome is low enough to protonate a high amount of the basic drugs inside the 
liposomes, and the pH outside is likewise higher, the drug will accumulate on the inside of the 
liposomes. The liposome formulation of Doxorubicin, Doxil®, is an example of a drug actively loaded 
by a pH gradient, by a so-called ammonium ion gradient. (Barenholz 2007). 
The ammonium ion can dissociate to form ammonia and protonated hydrogen (see equation 3). This 
dissociation is pH-dependent, so when a week base such as dFdC enters the liposome and binds H+ the 
pH will be stabilized because then more NH4
+ can dissociate to ammonia. The ammonium ion is 
basically trapped inside the liposome, while the non-ionic ammonia has a very high permeability 
coefficient. The leaving NH3 leaves a H
+ behind, and thereby the pH inside the liposomes is lowered. 
(Barenholz 2007)  
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Equation 3: NH4+ (aq)  NH3 (g)+ H+ (aq)   
(the equation being displaced  to the left at low pH, and to the right at high pH values) 
3.5 Dual asymmetric centrifugation 
Dual asymmetric centrifugation (DAC), also called speed-mixing, is a technique for blending highly 
viscous samples. Its use for producing liposomes was described by (Massing, Cicko et al. 2008). DAC 
differs from normal centrifugation, in which the vial not only rotates around one rotation axis, but also 
around its own center. So instead of the sample material being pushed outwards, as in a normal 
centrifuge, the additional rotation pushes the sample to the center of the vial (see figure 5.1). This 
combination of two rotating forces makes DAC a very good homogenizer. 
 
Figure 3.3. Schematic drawings of the principle of dual asymmetric centrifugation, (taken with permission 
from (Massing, Cicko et al. 2008)) 
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Viscous liposome formulations are very suitable for being made on DAC. Therefore it is ideal to 
produce VPGs.  
Liposomes produced by DAC have shown to be able to produce SUVs in a highly reproducible manner. 
The fact that it needs only one step, and that it is able to make very small batch sizes, makes it very 
suitable for experimental purposes. 
(Massing, Cicko et al. 2008)  
 
Figur 3.4. The speed mixer and a picture of the vial placed inside it. (Taken with permission from 






The aim of this study was to investigate different methods for actively loading gemcitabine, an anti 
cancer agent, into liposomes. The gold was to obtain a high trapping efficiency, and long shelf life. 
The primary aim for this study was to investigate whether there was possible making gemcitabine 
precipitate, and use this method to entrap it inside liposomes.  Previous observations had shown that 
gemcitabine precipitated in certain salt-solutions. Using the same salt-solutions inside liposomes to 
precipitate the gemcitabine could be a way of increasing trapping efficiency inside liposomes. This could 
also increase the stability and shelf life of the formulation compared to previous attempts. First approach 
was to find a suitable salt-solution for this purpose and the best conditions under which to conduct the 
experiment. Second approach was to test how well this method worked in liposomes. 
In order to develop the method and to have some trapping efficiencies to compare with I firstly made 
some experiments loading dFdC into liposomes via an ammonium sulphate gradient, an approach that 




5 MATERIALS AND METHODS 
5.1 Chemicals  
Table 1: Lipids 
Name of lipid Batch numbers Manufacturer 
EPC-3/ Chol – blend 
55/45 molar ratio 
Costume made 
899362-1/020 Lipoid GMBH, Ludwigshafen, 
Germany 
 
Table 2: Chemicals 





>99% 391607/1 33399 Fluka 
Acetonitrile > 99,9 % I426830 816 Merck, Germany 
















Chemical Quality Batch number Manufacturer 
Ammonium hydrogen 
sulphate 
>99% 1319144 42908161 Fluka analytical, 
SIGMA-ALDRICH, 
Germany 
Anion exchange resin 
(DOWEX 1 X 8) 
 
N/A 1220345 31906134 Fluka, 
SIGMA-ALDRICH, 
Germany 
Cation exchange resin 
(DOWEX® 50WX8-
200) 
N/A 14518LE SIGMA-ALDRICH, 
Germany 
Cross-linked dextran gel 













N/A 325 K19714474 Merck, Germany 
di-Sodium hydrogen 
phosphate dihydrate 
Na2HPO4*2H2O Lot: K26627780 927 Merck, Germany 






Ethanol denatured >99,8 38790760 
EG 2005786 
ROTH, Carl Roth 
Gemcitabine 
In the form of the drug  
45,40 % A437454 Lilly 
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Chemical Quality Batch number Manufacturer 
product 
Gemzar 1g, which also 
contains 
mannitol, sodium acetate, 
hydrochloric acid and sodium 
hydroxide 
A450409A 
Hydrochloric acid (HCl) 1 mol/L 0C346964 Merck, Germany 





(Triton X 100) 
N/A (unable to read) ROTH, Carl Roth 
KG, Germany 
Ortho-Phosphoric acid 85% Lot: K28790773 107 Merck, Germany 
Ortho-Phosphoric acid 
85% 
N/A K28790773 107 Merck, Germany 
Potassium dihydrogen 
phosphate 
99,5-100,5 A837173 719 Merck, Germany 
Sodium bisulphate 
anhydrous 
> 95,0% 1341669 53308015 Fluka analytical, 
SIGMA-ALDRICH, 
Germany 




99.0 – 102,0 % A191846 001 Merck, Germany 
Sodium Dihydrogen 99,0-102,0% 7910634610-2412997 MERCK, Germany 
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Table 3: Equipments 
Equipment Type Manufacturer 
Analytic balance Mettler AT26119 Delta Range 
N85171 
Mettler Toledo, Giessen 
Germany 
Bench top centrifuge Sigma 112 
~10.000 G 
Serial number: 41922 
Sigma 
Centrifuge, Benchtop  Sigma 112 ~10.000 g 
Serial number: 41922 
Sigma 
Cuvettes Einmal.Küvetten aus Polystyrol, 
4.5 ml 
ROTH, Carl Roth, Germany 
Eppendorf tubes (1,5 ml) LOT: T118728N Eppendorf, Germany 
Eppendorf tubes (2 ml) LOT: X132218J Eppendorf, Germany 
Fluorescence detector Luminescence Spectrometer 
LS 50 B 
The Perkin – Elmer Corporation 
Fluorescence detector software FL WinLab Versjon 3.00 The Perkin – Elmer Corporation 
Glasperlen (Glass beads), 
1 mm 
BBI-8541809 B. Braun Biotech International, 
Germany 
Heater plate Ikamag RCT IKA Labortechnik 
Heating/drying oven Heraeus, Serial-nr: 60393 Heraus Instruments GmbH, 
Germany 
HPLC – Main Columns: LiChrosphere 60 RP, Select B,  E. Merck (Darmstadt, Germany) 
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Equipment Type Manufacturer 
 250*4 mm (5 μm) 
LiChrosphere 100 NH2, 
250*4 mm (5 μm) 
 
E. Merck (Darmstadt, Germany) 
HPLC Precolumn LiChrosphere 60 RP, Select B, 
4*4 mm (5 μm) 
E. Merck (Darmstadt, Germany) 
HPLC Software Empower 2, version 6.00.00.00 Waters, Eschborn, Germany 
HPLC-system: 
Autosampler - Waters 717  
Column oven 
Pump - Waters 625 LC System  
System controller –  
Waters 600 E 










Waters, Eschborn, Germany 
Waters, Eschborn, Germany 
Waters, Eschborn, Germany 
Waters, Eschborn, Germany 
 
Waters, Eschborn, Germany 
Injection vial 10 ml, glass vial  
Laboratory balance Mettler PM 4000 (N88736) Mettler Toledo, Giessen 
Mini column separation LiChrolut incl. PTFE frits and 
glass columns 
Merck, Darmstadt, Germany 
PCS Software NICOMP Particle Sizing 
Systems 
CW388 Application Version 
1.68 
Samta Barbra, California, USA 
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Equipment Type Manufacturer 




PSS Nicomp 380 PSS, NICOMP, Santa Barbra, 
California, USA 
Pipettes Pipetman 200μL and 1000μL 
Eppendorf 20 μL, 100 μL, 50-






SpeedMixer DAC 150 FVZ (DAZ) Hauschild, Hamm 
Sterile Filter Disposable filter holders  
Rotilabo sterile 0,45μm 
60027042 
ROTH, Carl Roth, Germany 
Vacuum pump - KNF Neuberger 
Vortexer Reax 2000, 89447392 Heidolph, Germany 




5.3 Media and solutions  
25 mM Potassium dihydrogen phosphate solution 
Potassium dihydrogen phosphate buffer (KH2PO4) 25 mM, pH 6.9: 
i. Potassium dihydrogen phosphate 3.40 g 
ii. Distillated water 1000 ml 
iii. Hydrochloric acid for pH adjustment q.s. 
iv. Sodium hydroxide for pH adjustment q.s 
50 mM Potassium dihydrogen phosphate solution: 
• Used as dilution media for the VPG’s and as for eluting on Cross-linked dextran gel and ion 
exchange -columns. The reasoning behind this was to have a significant difference in pH 
between the outer and inner of the liposomes, the same osmotic pressure both outside and 
inside the liposomes, and, for AO, to have a stable pH when measuring at fluorescence. 
Potassium dihydrogen phosphate buffer (KH2PO4) 50 mM, pH 7.4: 
i. Potassium dihydrogen phosphate 6.80 g 
ii. Distillated water 1000 ml 
iii. Hydrochloric acid for pH adjustment q.s. 
iv. Sodium hydroxide for pH adjustment q.s. 
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Buffered Triton-X solution, 10%: 
• Used for cracking Acredine Orange (AO) liposomes in the preliminary experiments. 
Triton-X 10% (v/v) solution in KH2PO4-solution, adjusted to pH 7.4: 
i. Triton-X 10 g 
ii. Potassium dihydrogen phosphate -buffer 90 g 
iii. Hydrochloric acid for pH adjustment q.s. 
iv. Sodium hydroxide for pH adjustment q.s. 
Ethanol 20% solution 
• Used for preservation of the Cross-linked dextran gel columns when they were not in use 
20% Ethanol solution, 100 ml: 
i. Ethanol 15.8 g 
ii. Distilled water 80 g 
Gemcitabine 1mg/ml 
• Many different solutions of gemcitabine were made during the experiments. This one though, 
was used the most. 
Gemcitabine 1 mg/ml solution in water, 10 ml: 
i. Gemcitabine hydrochloride (Gemzar®) 22.0 mg 
ii. Distilled water ad 10 ml 




Gemcitabine 38 mg/ml 
• Mainly used in the precipitation experiments. 
Gemcitabine 1 mg/ml solution in water, 10 ml: 
i. Gemcitabine hydrochloride (Gemzar®) 1,674.0 mg 
ii. Distilled water ad 20 ml 
The gemcitabine was weighted into a volumetric flask, and then filled with the desired volume of 
distilled water. 
Glucose solution, 50 g/L 
• Used for maintaining a stable osmotic environment around liposomes containing 120 mM 
ammonium sulphate. 
50 g/L glucose solution, 500 ml: 
i. Glucose 25 g 
ii. Distilled water 500 g 
Mobile phase for HPLC analysis, for analyzing cholesterol 
• Used as the mobile phase when running dFdC and cholesterol on HPLC in the 1st set of 
experiments, and afterwards for just the running of cholesterol. 
Acetonitrile:Methanol:H2O, 67/30/3%, v/v/v, 1000 ml eluent: 
i. Methanol, according to 30% 237.00 g 
ii. H2O pH 2.3, according to 3% 30 g 
iii. Acetonitrile, according to 67 % 526.62 g 
The solution was then stirred by magnetic steering, and degassed for about 10 min with Helium, 100 
ml/ml before use. 
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Mobile phase for HPLC analysis, for analyzing gemcitabine 
• Used as mobile phase for gemcitabine detection. 
25 mM Potassium dihydrogen solution : Methanol, 92.5:7.5 %, v/v, 700 ml eluent: 
i. 25 mM Potassium dihydrogen solution pH 6.9, according to 92,5% 647.5 g 
ii. Methanol, according to 7.5%      41.5 g 
The solution was stirred by magnetic steering, and degassed for about 10 min with Helium, 100 ml/ml 
before use. 
Sodium chloride solution, 0,9 % (w/v) 
• Various uses for sustaining physiological osmolarity conditions 
0,9 % (w/v) Sodium chloride solution, 100ml: 
i. Sodium Chloride 900 mg 
ii. Distillated water 100 g 
Sodium chloride solution, 10% (w/v) 
• Used for preparation of the anion exchange columns. 
10 % (w/v) Sodium chloride solution, 500 ml: 
i. Sodium Chloride  50 g 
ii. Distillated water 500 g 
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Sodium chloride solution, saturated 
• Used in the preparation of the cation exchange columns. 
Saturated sodium chloride: 
i. Sodium chloride 200.0 g 
ii. Distilled water 500.0 g 
The solution was stirred with magnetic stirrer for about 15 min, and then stayed for about 10 min for 
the extra NaCl to sediment. Then it was filtrated into a flask via a 0.45 μM cellulose mixed ester (CME) 
syringe filter. 
Triton-X solution, 10 %: 
• Used for cracking dFdC containing liposomes 
Triton-X 10% solution: 
i. Triton-X 10 mg 
ii. Distillated water 90 mg 
 
Various salt solutions for testing precipitation of dFdC: 
• Used among other things in precipitation experiments with dFdC. 
120 mM Ammonium hydrogen sulphate((NH4)HSO4) solution: 
i. Ammonium hydrogen sulphate: 276.26 mg 
ii. Distilled water: ad 20.0 ml 
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120 mM Ammonium sulphate ((NH4)2SO4) solution: 
• Also used in the experiments trying to lade dFdC into liposomes via an ammonium sulphate 
gradient 
i. Ammonium sulphate: 1.586 g 
ii. Distilled water: ad 100.0 ml 
120 mM Ammonium phosphate (dibasic) ((NH4)2HPO4) solution: 
i. Ammonium phosphate (dibasic): 316.94 mg 
ii. Distilled water: ad 20.0 ml 
133 mM Ammonium phosphate (dibasic) ((NH4)2HPO4) solution, pH 7: 
• Used in the 4th sets of experiments, precipitating dFdC inside liposomes 
i. Ammonium phosphate (dibasic): 352 mg 
ii. Distilled water: 16 ml 
iii. Hydrochloric acid for pH adjustment   q.s. 
iv. Sodium hydroxide for pH adjustment   q.s. 
v. Distilled water: ad 20.0 ml 
pH was adjusted to 7, then filled up with water to get the desired concentration. 
120 mM Ammonium phosphate (monobasic) ((NH4)H2PO4) solution: 
i. Ammonium phosphate (monobasic): 276.07 mg 
ii. Distilled water: ad 20.0 ml 
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120 mM di-Sodium hydrogen phosphate dihydrate (Na2HPO4*2H2O) solution: 
i. Sodium hydrogen phosphate dihydrate: 427.181 mg 
ii. Distilled water: ad 20.0 ml 
120 mM Potassium dihydrogen phosphate (KH2PO4) solution: 
i. Potassium dihydrogen phosphate: 326.62 mg 
ii. Distilled water: ad 20.0 ml 
120 mM Sodium bisulphate (NaHSO4) solution: 
i. Sodium bisulphate anhydrous 288.14 mg 
ii. Distilled water: ad 20.0 ml 
120 mM Sodium dihydrogen phosphate (NaH2PO4) solution: 
i. Sodium dihydrogen phosphate monohydrate: 331.18 mg 
ii. Distilled water: ad 20.0 ml 





5.4 Preparative methods 
5.4.1 Preparation of VPGs by dual asymmetric centrifugation 
Preparation of VPG: 
Hydrogenated egg phosphatidyl choline and cholesterol (EPC-3/ Chol) mixture in a 55/45% molar 
ratio was mixed with an aqueous solution, in a 35/65% lipid/aqueous solution ratio.  
Glass beads, in the size of 1 mm in diameter, were added in equal weight with respect to the total 
weight of the batch size prepared. Shortly after weighing the constituents, the VPGs were prepared by 
DAC. The speed was set to 3540 rounds per minute (rpm), the maximum speed of the mixer. The 
mixing time was 6*5 min (total 30 minutes, 5 min is maximum runtime, so the speed mixer was 
restarted after every 5 minute) 
Dilution of VPGs: 
The VPGs were diluted with a 50 mM Potassium dihydrogen phosphate buffer, in the ratio 1:3, then 
speed mixed for 1.5 minutes * 2, handshaken a little bit between each time.  
5.4.2 Size exclusion chromatography 
Theory: 
Gel filtration, or size exclusion chromatography, is a simple and mild chromatography technique, 
separating molecules on the basis of difference in size. When separating components into two major 
groups according to their size range, it is called group separation. This technique can be used to remove 
high or low molecular weight contaminants. 
The gel filtration is based on the fact that in a gel, sufficiently small molecules (such as ions or drug) 
have the tendency to enter the pores of gel particles while bigger species such as liposomes, may not be 
able to enter into the pores of the gel at all (see figure 5.3). When not entering the pores, the large 
molecules and particles instead travel through the column at the same speed as the aqueous media used 
for elution of the column.  





Figure 5.1. Description on how SEC works. Big molecules (such as liposomes) pass around the pores and 
eluate first, while the smaller molecules can enter the gel, thereby having more volume to traverse the 
smaller molecules using longer time through the column. (Picture taken with permission from 
http://en.wikipedia.org/wiki/Image:Liposome_scheme-en.svg) 
Sephadex is a gel made from cross-linking dextran with epchlorohydrin. Different type of sephadex gel 
vary in degree of cross linking, and hence in their degree of swelling, and their selectivity for molecular 
sizes. The sephadex gels have names that start whit a G, and ends with a number. For example in 
Sephadex G-50, the “G” stands for gel, and “50” stands for the water regain of the gel, in the instance of 
G-50, 5.0 g water per g dry gel (N.N. 2007). Sephadex G-50 is suitable for separating large molecules, 
relative molecular weight (Mr) >30 000, from molecules with Mr under 1 500. That makes it suitable 
for separating liposomes from a salt in the outer phase. (N.N. 2002) 
Procedure: 
Packing of column 
The columns were prepared according to an internal method given to me by Vitorio. 
I. First I weight inn 250 mg Sephadex  G-50 into a 10 ml glass column with frits. 
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II. Added 4 ml of buffer (in the preliminary experiments: Potassium dihydrogen 
phosphate), and let it swell for one hour at 37oC. 
III. Exhausted the supernatant on maximum vacuum, constantly doubling the column 
volume of buffer. I did this one time with steering the content (to remove air), and the 
last time without steering. At the end I made sure the gel was covered by a little 
aqueous phase. 
IV. Next I added glass wails into the vacuum chamber. 
V. Added 500 μL liposomes to one of the columns, and exhausted with 500μL x the 
amount buffer needed to get all the liposomes out of the column. The liposomes could 
easily be distinguished from the surrounding water by that they color the water gray. 
VI. As described by the manufacturer (N.N. 2007), the column was washed with 2 column 
volumes of 0.2 M NaOH, and then re equilibrated with 50mM potassium dihydrogen 
phosphate. Under longer brakes the column was stored in 20 % ethanol solution.  
5.4.3 Active loading of dFdC into liposomes 
Experiments 
A fixed amount of dFdC was added to a fixed amount (volume) of liposomes solution. The liposomes 
were then loaded on water bath for 60 minutes at 650C. The water bath also had a steering option which 
was set to 200 rpm.  
5.4.4 Removal of outer drug by ion exchange 
Theory: 
Ion exchange is a technique used among other things for purification purposes. The principle of the 
method is to apply the sample we want to purify to a column with either positive charged resin material 
(anion exchanger), or negatively charged resin material (cation exchanger). The charge of the molecules 
in solution will decide if they will stay on the column or not. 
Gemcitabine is positively charged at low pH’s, where it binds to the negatively charged cation resin 
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material. Liposomes are pH neutral, making them pass through the column, together with its content of 
entrapped material. Separating entrapped from untrapped material is essential for determination of 
trapping efficiency. 
Packing columns for dFdC: 
I prepared the columns according to an internal method given to me by Vittorio Ziroli: 
I. 2 gram cation exchange resin was weight into a glass column with frits. 
II. The column was filled with water, then rested for 5 minutes for sedimentation. 
III. Water was exhausted with vacuum, but enough water was left to just cover the resin 
bed. 
IV. Column was loaded 3 times with saturated NaCl, 3*2 ml. I let the saturated NaCl stay 
in the column for 1 minute each. Column was exhausted with vacuum between each 
time, but enough water was left to just cover the resin bed. The column never ran dry. 
V. Column was then flushed with water 3* 2 ml, then rested for one minute each time, as 
for the NaCl solution. 
VI. Then 5 minutes of full vacuum, the column now ran completely dry. 
The ion exchange columns can only be used once, but the storage time is very long, since it is stored 
dry. 
Preparing columns for AO: 
The columns for AO were prepared in the same way, but with a few exceptions: 
 Anion exchange resin was used, not Cation exchange. 
 10% NaCl was used instead of saturated NaCl. 
Applying of samples: 
Volumes up to 1000 μL were applied slowly to the columns, and sucked off with about ~4-5 Hg 
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vacuum. Column was then eluated with 5 times 500 μL of water. Eluate was collected in test tubes of 
about 10 ml. 
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5.5 Analytical methods 
5.5.1 Photon Correlation Spectroscopy – PCS 
Theory: 
The PCS technique lets us see size and size distribution of particles in a liquid. Because liposomes will 
have different properties with different sizes as to loading and possibilities to accumulate in tumor cells 
this is quite useful information when making these vesicles. 
The principle behind PCS is based on that when light hits small particles compared to the wavelength 
used the light scatters in all directions. When using laser light one observes a fluctuation in the 
scattering intensity due to the fact that small molecules in a solution is undergoing Brownian motion. 
The scattered light can then undergo interference by surrounding particles. This intensity fluctuation 
contains information about the time scale of the movement of the scatters.  In the PCS-machine a laser 
beam of specified intensity polarization and wavelength are focused into the sample. A detector 
measures scattered light, and with the information gained from this the software is able to calculate size 
and distribution of the particles.  (Svanberg 2005; N.N. 2009b) 
Some rough intern reference values at the lab at Klinik für Tumorbiologie for "good" liposomes were as 
follows: Auto channel width: ~30, Mean diameter: <60 for the lowest channel widths 5 and 10, 
variance: 0.3, Chi squared: <30.  
Procedure: 
The VPGs were diluted to give an intensity between 250-350 kHz (ca a 1/2000 dilution). 
Measurements were done for 2*5 minutes on channel-width 5, 10 20 and AUTO.  The data was then 
compared to internal reference values. 
5.5.2 Quantification of Acredine Orange by fluorescence spectroscopy 
Theory: 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy that measures fluorescence from a 
sample. To get fluorescence a beam of light, usually ultraviolet light, is used to excite electrons in 
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molecules on certain compounds. When the electrons go back into position it causes them to emit light 
of a lower energy. At low wavelengths the fluorescence intensity will generally be proportional to the 
concentration of the substance we analyze. The wavelengths emitted depends on the molecule we 
analyses, and different substances emits lights in different wavelengths. Because of this substance 
specificity the substance can often be analyzed without separating it from other substances in the sample 
(unlike for example UV).  
Procedure: 
Samples of acredine orange were diluted to a measurable concentration for the PCS, and then measured 
with an excitation wavelength of 490, and emission wavelength was set to 520. Integration time was 
30secounds.  
5.5.3 Quantification of gemcitabine through Reversed-Phase High Performance 
Liquid Chromatography –RP-HPLC 
HPLC theory: 
HPLC is much used method for separating substances. Much of its success probably lies to it's 
simplicity. In simple terms we can say that a HPLC consist of a mobile phase (also called eluate), a 
pump, injector port, a sampler, a pre-column, main-column and a detector (often UV). The mobile 
phase acts as a carrier for the sample solution. The sample is being injected to the mobile phase through 
the injector port, and floes through the column were substances in the solution get separated. To 
separate substances the column must have properties that delay their flow based on their structure. In 
reversed phase chromatography (which is what I use) the stationary phase is non polar, while the mobile 
phase is polar. This increases retention time for non polar substances, while polar molecules elute 
faster. When the sample goes through the detector we get a peak in our chromatogram which aria 
under the curve corresponds to its concentration (at least to a certain extent). 
Procedure 
Before HPLC the liposomes were cracked by adding 10 % triton-X to the liposomes, giving a triton-X 
concentration of > 3% in the liposome-sample. The Solution was then further diluted by a 25 mM 
Potassum dihydrogen solution to. This was done to give a concentration of triton-X of under 1%, and to 
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make sure the pH was in the right range for measuring, before applying the sample on the HPLC.  
In the first set of experiments I used an HPLC-method for running and analyzing Gemcitabine and 
Cholesterol in the same run. This method however, did not separate triton-X (used for cracking the 
liposomes) from the gemcitabine. For that reason I went on to use another internal method. 
Procedure for analyzing dFdC and cholesterol in the same run: 
This method was obtained from Vittorio Ziroli, and was called “Simultaneous detection of Gemcitabine 
and Cholesterol in a vesicular phospholipids gel by HPLC to determine encapsulation efficiency”. The 
advantage of being able to analyze both dFdC and cholesterol in one run is that it saves time, and also 
makes it possible to compare amounts of dFdC and cholesterol directly.  
The parameters on the HPLC were set according to Ziroli, and are listed in table 4. 
Table 4: HPLC parameters used in the preliminary experiments for quantification of 
gemcitabine 
Injection volume 10 μL 
Mobile phase Acetonitrile / Methanol/ H2O (acidified) 67:30:3 
Flow rate 1.5 ml/min 
UV detection wavelength 0-6.5 min: 278 nm 
6.5-10 min: 215 nm 
Column temperature 300C  
Columns LiChrosphere 60 RP, Select B, 250*4 mm (5 μm) 
with a guard column: 
LiChrosphere 100 NH2, 250*4 mm (5 μm) and 
LiChrosphere 60 RP, Select B, 4*4 mm (5 μm) 
According to Zirolis method the sample was suppose to be diluted in ethanol/methanol 90/10. To 
crack liposomes with a dilution like this, and without triton-X you will need a dilution of about 1:100. 
However, this was impossible in my case, as the dilutions made on the Cross-linked dextran gel and ion 
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exchange columns made the lipid concentration to small for much further dilution. 
Analyzing dFdC and cholesterol separately by the “old” method 
This method was given to me by Ziroli. 
HPLC determination of dFdC 
Table 5: HPLC determination of dFdC 
Injection volume 50μL 
Mobile phase Phosphate buffer (PBS) 25 mM, pH 6.9 / MeOH 
92.5 : 7.5 (vol/vol) 
Flow rate 1 ml/min 
UV detection wavelength 278 nm 
Column temperature 40
0C  
Columns LiChrospher 60 RP-select B, endcapped, 5μm, 
250 x 4 mm, with a guard column LiChrospher 
60 RP-select B endcapped, 5μm, 




HPLC determination of Cholesterol 
Table 6: HPLC determination of Cholesterol 
Injection volume 10μL 
Mobile phase acetonitrile/methanol/H2O  67/30/3 
Flow rate 1.0 ml/min 
UV detection wavelength 215 nm 
Column temperature 400 C  
Columns LiChrosphere Select B, 5 μm, 250 x 4mm (C8-
column), with gard column  
LiChrosphere Select B, 5 μm (4 x 4mm) 
Autosampler temperature 40C 




6 RESULTS AND DISCUSSION 
6.1 Preliminary experiments 
6.1.1 Acredine Orange 
Procedure 
Liposomes were prepared by DAC, having an ammonium sulphate gradient. 50mM Potassium 
dihydrogen phosphate solution was used as dilution medium. Outer Amonium sulphate was removed by 
size exclusion chromatography. A solution of Acredine orange (AO) was then added to the solution of 
liposomes, and the samples were incubated on water bath at 650C, for about 1 hour. After samples were 
cooled to room temperature, free Acredine orange were removed by anion exchange chromatography. 
Samples were cracked with Triton-X 10 %, and then further diluted with 50mM Potassium dihydrogen 
phosphate solution down to a measurable concentration for the fluorescence spectrometry. For 
comparison reasons part of the sample that had not undergone anion exchange, thus containing bouth 
free and entrapped dFdC, I choose to call 100% samples. These were also cracked with triton-X and 
diluted in a similar manner, before being measured at fluorescence. Amounts of AO were determined 
by comparing the intensity yield in the spectrometry to a standard curve. Trapping efficiency was 
determined by dividing the amount of entrapped AO on the amounts measured in the 100% sample. 
Making of standard curve 
Because Acredine orange is a base it was assumed that pH could affect its fluorescence properties. I also 
proved this by trying to measure AO diluted in a highly acidic solution. This gave very low intensity in 
the spectrometer, showing that the pH is an important factor. Because of that, all samples were buffered 
to pH 7.4, using a 50mM Potassium dihydrogen phosphate solution. To test if this was a stable range I 
measured intensity of 1μM and 2μM dFdC at the pH 6, 7.4, and 8. The result can be seen in table 7. 




Table 7: Variation of intensity measurements on AO at different pH’es 
Concentration of AO 1 μM 2μM 
pH 6 278 594 
pH 7,4 226 526 
pH 8 236 503 
From this conclusion I made a standard curve in pH 7.4, ranging from 0.5 μM, 1μM, 2μM, 2.67 μM, 
and 4 μM, 2 parallels of each concentration (see figure 6.1). 
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Figure 6.1. Standard curve of Acredine Orange measured at fluorescence spectrometer, ranging from 0.5 to 
4 µM in concentration. 
Results 
The measured absorbance was much higher than the theoretical values, both in the 100 % samples (the 
samples that contained both free and encapsulated AO), and in the entrapped samples. For example in 
 
  42
one experiment the concentration should theoretically be around 0.8 μM AO, but the intensity 
indicated 1.80 μM. By comparing the entrapped samples with the 100 % samples though, I was able to 
calculate trapping efficiencies, varying from 60 to over 80%.  
After 3 experiments that both showed the trend with intensity higher than it theoretically should be, 
and after lots of recalculations revealing no errors, I got the idea that something was influencing my 
samples. I tested about everything I could think of, measuring many of my solutions on the fluorescence 
to see if they gave any peak on the fluorescence (they were all blank, including the triton-X). Then I got 
the idea to mix AO solution with 5 % triton-X (the next step would have been to mix them with 
cholesterol to see if that had any effect). The results from this showed that samples containing triton-X 
gave a higher intensity in the fluorospectrometer than we could expect from just acredine orange. (see 
table 8): 
Table 8: Intensity measurements of similar solutions of AO, with and without 5 % triton-
X. 
Concentration of AO Intensity with 5% triton-X Intensity without triton-X 
2 μM 999 (to high to measure) 600 
1 μM 523 -  
0.5 - 139 
0.25 μM 101 68 
To prove this correlation between triton-X and intensity, and to show that it also gave effects down to 
concentrations as low as 1% triton-X a new experiment was made with more parallels. This showed the 
same thing, and also that a triton-X concentration of only 1% also affected the measurement of 




Table 9: Intensity measurements of similar solutions of AO, with and without 1% Triton-
X. 
Concentrations Intensity with 1% triton-X Intensity without triton-X 
4μM AO, 1%  999.999 975.043 
3μM AO, 1% 999.999 732.653 
2μM AO, 1% Triton-X 768.760 461.728 
1μM AO, 1% Triton-X 306.021 162.190 
 
As the concentrations with triton-X was higher in the entrapped samples than in the 100 % samples, this 
also lead to some serious problems on how to proceed. 
One way this could have been solved was to have the exact same concentration of triton-X in all 
cuvettes. Another is to run these substances on HPLC, separating AO and triton-X before 
measurements. But at least the HPLC approach would have needed lots of adjustments finding a perfect 
column and mobile phase. Since this was only a preliminary experiment it was limited how much time 
and effort it should be given, so instead it was decided to move on to experiments on gemcitabine. 
But at least the experiment showed that there was an encapsulation of AO into liposomes, as triton-X 
did not give any absorbance alone. Encapsulation could also be observed as the liposomes filled with AO 
sediment in the test tubes when left over night (Free AO in water doesn’t sediment). 
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6.2 Experiments loading gemcitabine into liposomes via an 
ammonium sulphate gradient 
6.2.1 1st set of experiments; loading of dFdC via a Ammonium Sulphate gradient, 
followed by detection dFdC and cholesterol analyzes in one run 
The dFdC liposomes were prepared in a similar manner to the AO, biggest exception being the use of a 
cation exchange column instead of an anion exchange column. Before HPLC the solution of cracked 
liposomes and triton-X were diluted with 25mM potassium dihydrogen solution. 
As method for analyzing amount of dFdC HPLC was used. The parameters that were used can be found 
under section 5.5.3, Procedure for analyzing dFdC and cholesterol in the same run. 
Results 
As the internal method for the HPLC, Procedure for analyzing dFdC and cholesterol in the same run, 
had been used several times in the lab at "Klinik für Tumorbiologie", we did not expect any big 
problems to occur. Especially after producing a perfect calibration line including both dFdC and 
Cholesterol (not included here, as it was never used). The problems, though, occurred as soon as we 
started applying the samples of loaded liposomes. All the samples contained a big top right where 
gemcitabine was supposed to be (see figure 6.2 and 6.3). Problem was that it was much bigger than the 





Figure 6.2. HPLC run of a 100% sample, containing dFdC and cholesterol, liposomes cracked with  
triton-X. 
 
Figure 6.3. One of the standards.  Sample contains dFdC and Cholesterol, but no Triton-X. 
First thought was that I had made a mistake, either in the calculations, or somehow in the preparations. 
It was decided I should conduct a new experiment, and make the calculations one more time. But the 
result was the same. The thought that some of the solutions I used in the experiment might have caused 
this peak, one way or the other entered my mind. So I started applying everything from the water (in 
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case it was polluted) to my buffer solution on the HPLC (but coincidently the Triton-X was left out). 
Also Ziroli vent over my calculations of the dilution steps, finding no errors. 
The answer first appeared when looking for cholesterol content in not loaded liposomes. According to 
procedure the liposomes were cracked with Titon-X, and then further diluted, before being applied to 
the HPLC. As the result looked just like figure 6.2, one big top and one small cholesterol top, this gave 
a clear indication as to what was wrong. Since this sample contained no dFdC, but only liposome 
content and Triton-X, it had to be Triton-X. This was proved by applying different concentrations of 
Triton-X to the column, which gave the same top at the same location. 
The reason why this had not been discovered earlier in the method was that when it had been used at 
the lab they did not crack the liposomes with triton-X, but by heavily diluting them in 
ethanol/methanol. This was possible since in their experiments they only passively loaded liposomes, 
and thereby did not have to use size exclusion chromatography. Thereby their liposomes were not so 
diluted at the end. This was not a possibility for me, so I had to find another way. 
My first thought was to adjust some of the preferences on the HPLC, such as the flow speed, adjusting 
the content of the mobile phase, and even removal of one of the columns. After trying several 
modifications, we gave up, and moved to an older method, used previously without problems at the 
Klinik für Tumorbiologie. 
6.2.2 2nd set of experiments; loading of dFdC via a ammonium sulphate gradient, 
followed by separate detection of dFdC and cholesterol 
Procedure 
Preparation 
The liposomes and the dFdC were prepared in a similar manor to the 1st set of experiments, and 
descriptions of the methods used can be found in section 5.4, Preparative methods. I prepared liposome 
batches of 1000mg each time, with 350mg lipids and 650μL 120mM ammonium sulphate. VPG's were 
diluted 1/3 adding 2000μL 50mM potassium dihydrogen phosphate solution (PDP-solution). The 
diluted liposomes were then separated into 4 parallels, and diluted once more, ½, before applying them 
to columns containing cross-linked dextran gel according to section 5.4.2, "Size exclusion 
chromatography". 2000μL of each eluate from the cross-linked dextran gel was extracted and 250 μL 
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1.0 mg/ml dFdC was added to this, resulting in a dFdC-concentration of 0.11111 mg/ml. The 1.0 
mg/ml dFdC solution was gemzar mixed with water. 
Because of variations in amounts of eluate used on the cross-linked dextran columns the concentration 
of cholesterol that came out of the column varied a bit. Normally the dilution was about 1/7. 
The liposomes + dFdC 0.111 mg/ml, total volume being 2250μL, were transferred to sealed test tubes 
of 10ml. These were placed on water bath at 650C for 1 hour, at 150 RPM (to avoid sedimentation and 
enhance loading).  
Removal of outer drug before analysis was preformed by ion exchange as described in section 5.4.4, 
Removal of outer drug by ion exchange. In addition to running the samples through these columns, a 
control-sample containing the equal or higher concentration of dFdC as the liposome-samples was also 
rand through a column, with the same conditions as the other columns. The reason behind this was to 
check that the columns were working and able to remove all free dFdC that was applied. 
The samples ran through the ion exchange columns (thus containing only entrapped dFdC) I choose to 
call "loaded samples", while the samples containing both free and entrapped dFdC I choose to call 100% 
samples. 
Analyzing 
Parts of the liposome-batch produced was extracted and diluted with 50mM Potassium dihydrogen 
phosphate solution to measurable concentrations for the PCS, according to section 4.5.1, "Photon 
Correlation Spectroscopy – PCS" (except in experiment 6, where I diluted two of the samples with a 
50g/L glucose solution prior to the PCS).  
Prior to the analyses on the HPLC the dFdC-samples were diluted to a theoretical concentration of 
about 6μg/mL. For the loaded-samples this means the theoretical concentration assuming there is 100% 
loading-efficiency. The parameters of the HPLC can be found in section 5.3, "Analyzing dFdC and 
cholesterol separately by the "old" method". 
Things not specified in this paragraph (procedure) or in the paragraphs which that are referred to, 





Standard curve of gemcitabine 
I made a standard curve for gemcitabine ranging from 100 to 7200 ng/ml dFdC. R2=0.993410 (see 
figure 6.4).  
 
Figure 6.4. Standard curve of gemcitabine, ranging from 100 to 7200 ng/ml dFdC.  
X-axis: Concentration of dFdC (ng/ml). Y-axis: Aria under the curve. 
Standard curve cholesterol 
In a similar way I also made a standard curve for cholesterol, ranging from 400 to 3200 μg/ml, 




Figure 6.5. Standard curve for cholesterol, ranging from 400 to 3200 µg/ml.  
X-axis: Concentration of cholesterol (µg/ml). Y-axis: Aria under the curve (AUC). 
Experiment 1 
To eluate the sample on the ion-exchange column the 50mM Potassium dihydrogen phosphate (PDP)-
solution was used. Reason for this was that I thought it would be best to keep the liposomes in an 
osmotic environment until they had passed the ion exchange column completely.  
All samples were diluted to a theoretical concentration of around 4μg/ml before applying them to the 
HPLC. 
The loaded samples gave no visible peaks on the chromatogram, indicating no loading. Also, the control 
sample was positive indicating that the ion exchange column had not worked properly. 
Analyzing the cholesterol revealed that the cholesterol-values in the expected range, with a few strange 
exceptions on parallel 4 of the loaded samples (78% over the expected value), and parallel 2 of the 
100% samples (750% over the expected value). 
The results from the PCS were in the expected range, indicating that there was nothing wrong with the 
liposomes size or size distribution. 
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The full results from experiment 1 can be found in appendix 1. 
Experiment 2 
In an internal method for the ion exchange column, used at Klinik für Tumorbiologie, water is used as 
the eluting liquid. Also (Gravem 2006) used water as eluting agent. At this point there were no clear 
indications that using the PDP-solution was the reason for the positive control-solution, though I saw no 
reason to experiment with it if the method could work without the PDP-solution as eluate. 
All samples were diluted to a theoretical concentration of 6.225μg/ml prior to HPLC. 
The control sample was negative (did not contain dFdC), but so were all the loaded samples. The 100% 
samples ranged around 6μg/ml as expected, indicating that there was nothing wrong with the dilution-
steps. 
The cholesterol samples showed values over their expected theoretical values, the reason for this being 
somewhat unclear. 
The full results from experiment 2 can be found in the appendix 1. 
Experiment 3 
Experiment 2 showed no trapping-efficiency at all. The only big change I had made since the 
preliminary experiment with the Acredine Orange (were the loading had worked) were to change the 
eluate at the ion exchange column to water. So I thought that maybe applying the 50mM PDP- solution 
on the ion exchange column was necessary for the osmotic pressure. This impression was also the one of 
my lab supervisor, which also meant that using the solution as an eluate at the column would not affect 
its ability to bind free dFdC. 
For that reason I used the 50mM PDP-solution when eluting the column. All samples were diluted to a 
theoretical concentration of 4.15ng/ml. 
The loaded samples indicated a trapping-efficiency of over 50%. But the control-sample was positive, so 
the data was not valid and had to be discarded. The cholesterol values would probably not have revealed 
anything more, so they were not measured. 




My results from experiment 1, 2 and 3 indicated that the use of the 50mM PDP-solution to eluate the 
ion exchange columns made lots of free dFdC pass through the column. To investigate this further I 
made 4 columns, and applied 1000μL of 0.111mg/mL dFdC solution to each of them. Two of the 
columns were eluated with water, the other two with the PDP-solution. All was done according to 
5.4.4, "Removal of outer drug by ion exchange". The solutions were not diluted further, but measured 
right out of the ion exchange-columns. This gives a theoretical concentration of 31.7μg/mL dFdC if all 
went through. The result can be seen in the table below. 
Table 10: Testing of different eluate and they're effect on the columns ability to retain free 
dFdC. 
Sample Control 1, Water Control 2, Water Control 3, 50mM 
PDP-solution 
Control 4, 50mM 
PDP-solution 





0 126.3ng/mL 875ng/mL 3052ng/mL 
 
The numbers were not totally as expected. One of the samples eluated with water contained a little bit 
dFdC, and the ones eluated with the PDP-solution did not reveal as high concentration as one would 
expect from the earlier experiments. But combined with the results from experiment 1-3, the 
indication that the PDP-solution did not work well with the column was quite clear. 
Experiment 5 
Being very optimistic I thought that the PDP-solution was the only problem, and ignored experiment 
2's failure as a coincidence. I eluated the ion exchange column with water, and diluted all samples to a 
theoretical concentration of 6μg/mL. 
The result was empty "loaded"-samples, but also a blank control-sample. The 100% samples were in 
the right range (around 6μg/ml). 
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The cholesterol samples were also in the expected range. Results can be found in appendix 1. 
Experiment 6 
The latter experiments gave rice to some questions whether why we did not get any loading. In 
(Gravem 2006) experiments with loading dFdC into liposomes via an ammonium sulphate gradient she 
used a solution of 50g/L glucose as hydration media for the VPG's. At the time I figured it would be a 
good idea to test if this could have any influence on the loading. 
The point of the experiment was to see ones more how the PDP-solution affected the ion exchange 
column, in addition to see if the PDP-solution as a dilution medium for the liposomes had any negative 
effect on the loading, compared to using a glucose-solution. Also I wanted to se if any of the non 
existence results from the previous experiments could have any connection to the use of water to eluate 
the ion exchange column (because of osmotic pressure), and if e.g. the glucose solution could be used 
for this purpose instead. 
To test this I made two batches of liposomes. One batch contained 50mM PDP-solution as outer aqua's 
phase, and one contained 50g/L glucose as outer aqua's phase. Each batch was then divided in two, 
where one part was for eluting the sample on the ion exchange column with the same liquid as used as 
dilution media for the liposomes (PDP-solution or glucose-solution), where the other parts were 
eluated with water. For each parallel I had a control-sample containing free dFdC to test the ion 
exchange column for the specific eluate-media. All samples were diluted to a theoretical concentration 
of 6.0μg/mL before they were analyzed on HPLC. 
The results were much as we could have been expected out of the previous experiments. The samples 
eluated at the ion exchange column with the PDP-solution contained dFdC, but so did the control 
sample. All other samples were negative for dFdC. The results in detail can be found in appendix 1. 
The PCS-results for the liposomes produced with PDP-solution as outer phase showed a very high auto 
channel width, at 99 (reference value is about 30), which mean diameters of over 300, and Chi squared 
of over 500. The other channel widths were normal. This might indicate that there were some very 
large liposomes in the batch. Though this could have affected the liposomes ability to load, all the other 




The results showed no loading at all. The minimum detectable amount of dFdC on the HPLC is lower 
than 100ng/ml. When the loaded samples are diluted to a theoretical concentration of 6μg/ml dFdC 
we should be able to detect loading efficiencies even lower trapping then 1.7%. So this means that 
loading must have been even lower than this. 
Maximum theoretical loading 
If we assume that the volume ratio between outside and inside of the VPG's we produce is 40%, the 
dilution steps before loading would result in a concentration of  0.847% of the total water content 
being inside the liposomes at loading (see appendix for calculations). Hence if there were only passive 
loading we would have gotten a loading of maximum 0.847%.  
The total molar concentration of dFdC in the solution is 0.4217mM. In a solution of 2250μL, which 
was the amount that was used in these experiments during loading, that means that we have 0.9488 
μmol dFdC in the solution. At 0.847% loading, the number we could expect from passive loading, 
8.036*10^-3 μmol is loaded. (Calculations: see appendix 1) 
The fact that the concentrations of the liposomes may also play an important role was unfortunately not 
taken into consideration, mainly because the loading with acredine orange (AO) worked fine. But there 
is a major difference between AO and dFdC. While AO has a pKa of 10.45 the dFdC has a pKa of 3.58 
(N.N. 2005; Barenholz 2007). If the pH inside the liposomes were let's say 3, because of the 
ammonium sulphate gradient, then according to the Henderson-Hasselbalch equation the amount of 
charged AO would be near 100% (calculations can be found in appendix 1). 
For the dFdC on the other hand, a pH of 3 would lead to only 3.8 times as much charged dFdC as 
neutral, meaning that 79% is charged. (pH 3 is not necessary the real pH inside the liposomes. If the pH 
inside the liposomes were 2.5, about 92% of the dFdC would be charged.) pH outside the liposomes 
were 7.4, meaning that under 0.02% of the dFdC (1.898*10^-4 μmol) would be charged outside the 
liposomes. For simplicities sake in the calculations we can therefore assume that no dFdC outside the 
liposomes are charged.  
To the VPGs 120mM ammonium sulphate were added, giving an AS solution of 78mM in the "VPG-
soup". Assuming 40% loading the volume the amount of AS would be 1.486 μmol ammonium sulphate. 
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(For calculations, see appendix 1) 
According to theory (see section 3.4, active loading) the charged dFdC will get "stuck" inside the 
liposomes, while the rest will diffuse in and out randomly. Every time some dFdC get "stuck" inside the 
liposomes more dFdC will diffuse to the inside, so that the percentage of uncharged dFdC compared to 
the outside is the same all the time.  
Using the numbers from above, where passive loading gives 0.847% loading and charged dFdC inside 
the liposomes will be 79%, we are able to calculate the theoretical maximum loading under this 
conditions (see appendix 1). This maximum loading would then only be 4.03%, or 0.0398 μmol dFdC 
loaded. This loading efficiency should have been detectable, though the loading almost never get as high 
as the theoretical maximum, due to liposome shape, etc. This is was also thought-experiment, and we 
can not be sure of all values given (such as pH inside the liposomes and the amount of water inside the 
liposomes). These theoretical values probably give a better loading than we would get experimentally 
under these conditions. So when even these values gives a maximal loading efficiency of only 4.03% it is 
pretty clear that the concentrations of the liposomes were to low to give high loading-efficiencies of 
dFdC. 
Other factors 
There is hard to find other factors that would lead to loading of AO but not of dFdC since there were 
no special differences between the preparative techniques used. Though since we have no useful loading 
efficiency data from the AO either we don't know how good this loading were (only that it was visible). 
So there is nothing wrong discussing factors that were similar between AO and dFdC. 
Loading conditions 
The loading of the liposomes were conducted in small sealed test tubes of about 10ml, where the liquid 
took 2.25ml of the space. As mentioned in the introduction chapter 3.3, "Active loading", the loading 
via an ammonium sulphate gradient depends on the ammonia molecule (NH3) leaving the system by 
evaporating as gas. Unable to find any info from what has previously been done about this I don't know 





When looking back on these experiments I also see that factors for adjusting the osmotic pressure were 
not optimal. While 120mM ammonium sulphate has about the same isotonicity as 0.9% NaCl 
(118.2mM is the exact concentration of isotonicity of ammonium sulphate), the isotonic value for 
potassium dihydrogen phosphate is at 160.18mM (in my experiment I used 50mM). Also the dFdC-
solution that I used was not adjusted for isotonicity (the right way to do this would have been dissolve 
the Gemcitabine in 0.9% NaCl instead of water, according to its SPC (N.N. 2006)). 
Theoretically this would create a hypotonic environment for the liposomes, causing them to swell, or 
even crack. On the other hand the PCS-results look fine also when compared to the 50g/L glucose 
solution used in experiment 6.   
6.3 Precipitation experiments 
6.3.1 Background 
It is known (N.N. 2006) that concentrated solutions of Gemcitabine (38 mg/ml) have a tendency to 
form precipitates, when stored in the fridge. Scientists at Klinik für Tumorbiologie had earlier observed 
that gemcitabine, especially when dissolved in a phosphate buffer then stored in the fridge shows 
precipitate and forms crystals. Trying to dissolve these crystals proved very difficult, even after stirring 
them in room temperature. Since this was undesirable it had not been documented further at this time. 
Although precipitation most often is an undesirable process, it might theoretically be used when actively 
loading liposomes. A hypothesis was that the mechanism were that 2 dFdC(+) binds to HPO4(2-), and 
leads to a insoluble salt, having liposomes with an inner phosphate solution would be a way of actively 
loading dFdC into liposomes. Though there were also a possibility that the precipitation were a direct 
consequence of low solubility at the higher pH-values combined with the storing in the fridge. 
Therefore all of these things were needed to be investigated further. 
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6.3.2 3rd set of experiments; finding the right salt and conditions for 
precipitation of dFdC 
Experiment 1 
As mentioned above the results from the precipitation of the dFdC previously observed was not 
documented in any way. Also we wanted to see if more than just the phosphate-salt would make this 
precipitation happening. To start somewhere the salts sodium bisulphate anhydrous, ammonium 
sulphate, ammonium phosphate (monobasic), ammonium phosphate (dibasic), sodium dihydrogen 
phosphate (monobasic) and ammonium hydrogen sulphate were tested first. An important thing was 
that I tested both phosphate and sulphate-salts. 
As we had no sponsored gemcitabine, but had to pay for it ourselves it became an issue throughout the 
whole theses to try to minimize the use of this substance. So though the first thought when trying to 
make a substance precipitate is to use as high concentration as possible, it was decided to first try with 
only 0.5mg/ml dFdC. The concentrations of the salts were set to a concentration of 60mM. This was 
achieved by mixing 1mg/ml dFdC with 120mM of each salt in a 1.5ml reaction tube. I also made one 
sample which only contained the dFdC-solution and water, to compare to the rest of the samples. 
I made 6 parallels out of every salt. Two samples of each salt-type were placed in an oven at 500C, two 
in room-temperature, and two in the fridge (~60C), all for about six hours. The reaction-tubes were 
then centrifuged on a bench-top centrifuge for 1.5 minutes, prior to extraction of 100μL of the 
supernatant. The extracted supernatant was immediately diluted 1/10 in water, to prevent further 
precipitation. Then later it was diluted to the theoretical concentration of 6μg/ml, prior to measuring 
at the HPLC. Since the samples contained no liposomes triton-X was of course not used, but the last 2 
steps with dilution was always done using 25 mM potassium dihydrogen phosphate solution.  
No precipitation could be observed by the naked eye. An HPLC analysis of the supernatant gave the 
results seen in the table below. The concentrations were calculated by comparing the AUC with the 
standard curve presented in section 6.2.3, 2nd set of experiments. 
 
  57
Table 11: Precipitation experiment 1, (average and standard deviation of 6 parallels). 
Concentrations determined by HPLC (comparing AUC with the standard curve 













Freezer 1 5781 ng/ml 5741 ng/ml 5919 ng/ml 5657 ng/ml 
Freezer 2 6204 ng/ml 6236 ng/ml 6512 ng/ml 5985 ng/ml 
Room 1 5761 ng/ml 5740 ng/ml 5648 ng/ml 5730 ng/ml 
Room 2 5737 ng/ml 6497 ng/ml 6513 ng/ml 6120 ng/ml 
Oven 1 5751 ng/ml 5755 ng/ml 5738 ng/ml 5524 ng/ml 
Oven 2 5753 ng/ml 5382 ng/ml 4844 ng/ml 5985 ng/ml 
Average 5831 ng/ml 5892 ng/ml 5862 ng/ml 5834 ng/ml 
Standard 
deviation 167   367   570   210   










in water only)   
Freezer 1 5212 ng/ml 5057 ng/ml 4498 ng/ml   
Freezer 2 6302 ng/ml 5712 ng/ml 4629 ng/ml   
Room 1 5485 ng/ml 5611 ng/ml 5536 ng/ml   
Room 2 6026 ng/ml 5975 ng/ml 4828 ng/ml   
Oven 1 5864 ng/ml 5821 ng/ml 5719 ng/ml   
Oven 2 6133 ng/ml 5131 ng/ml 5514 ng/ml   
Average 5837 ng/ml 5551 ng/ml 5121 ng/ml   
Standard 
deviation 377   342   483     
 
Since these concentration-numbers here are the amount of dFdC in the supernatant, the less dFdC that 
is detected, the more should have precipitated. It might look like ammonium dihydrogen sulphate 
shows a little bit lower concentrations than the rest. But the control sample (containing only water and 
dFdC) gives an even lower concentration of dFdC. All in all it seems like the small differences seen here 
are random, and may for example be a result from small differences under the pipetting. So, at the 
extremely low concentration of dFdC chosen for this experiment (0.5 mg/ml) with none of the salts 
precipitation of dFdC could be detected. 
Experiment 2 
When trying to find out which salt that had been used last time that had induced dFdC to precipitate, 
Massing suggested that I try ammonium phosphate (monobasic) and higher concentrations of dFdC. I 
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made 4 samples with decreasing amounts of dFdC; 20mg/ml (76mM), 10mg/ml (38mM), 5mg/ml 
(19mM) and 0.5mg/ml (1.9mM). The samples were made by mixing a 38mg/ml dFdC-solution with a 
120mM solution of the salt. Therefore the higher concentration of dFdC, the lower the concentration of 
ammonium phosphate (monobasic) was, ranging from 57mM and up. When looking at these variations 
in concentrations of the salt it is clear that it was not planned good enough in advance, since the sample 
with the highest dFdC concentration, 76mM, had a higher molar concentration than ammonium 
phosphate (monobasic), 57mM. Though the difference was not that big, so if there was binding between 
the salt and the dFdC it should give detectable amounts of precipitation. 
All 4 samples were placed in the fridge over night (about 18 hours), temperature being around 60C. The 
samples were then centrifuged on a benchtop centrifuge for 1.5minutes, followed by extraction of 
100μM supernatant.  
No visible precipitation were observed or detected on the HPLC. 
Experiment 3 
It was suggested that I tried to get concentrations of dFdC as high as 38mg/ml (maximum 
recommended concentration according to the manufacturer). This was achieved by weighing the dFdC 
powder directly into the reaction tubes, followed by adding the salt-solutions. Concentrations of the 
salts added were 120mM. All the same salts as in experiment 2 were used. The final concentration of 
dFdC was 38 mg/ml (114 mM), and all the salts 120 mM (so the molar ratio was close to 1). After 
mixing the gemcitabine powder with the salt-solutions all dFdC dissolved, except the mix with the 
ammonium phosphate (dibasic), where some undissolved powder was seen. To investigate this further I 
made mixtures of the salt-solution and dFdC-powder, resulting in final dFdC-concentrations of 20 
mg/ml (76mM), 15 mg/ml (56mM), 10 mg/ml (38mM) and 5 mg/ml (19mM). The 20 mg/ml and 
the 15 mg/ml did not dissolve either, while the rest seemed to dissolve. All samples were placed in the 
fridge (~60C) over night (about 20 hours). The samples were then centrifuged on a benchtop centrifuge 
for 1.5minutes. 100μL were taken and immediately diluted (1/10) to prevent further precipitation. 
Samples were later diluted down to a theoretical concentration of 5μg/ml, and analyzed on HPLC. 
When investigating the samples after the night in the fridge there seemed to be no difference from the 
observations made the day before. dFdC-concentrations of 15 mg/ml and above in ammonium 
phosphate (dibasic) showed a cake indicating that they had not (completely) dissolved, while there was 
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no visible precipitation in the other samples. Analysis by HPLC confirmed this (see the table below). 
Table 12: Calculated precipitation of gemcitabine based on the measured concentrations 



















concentration 38 mg/ml 38 mg/ml 38 mg/ml 38 mg/ml 38 mg/ml 
Measured 
concentration in 
supernatant 5001 ng/ml 5021 ng/ml 4987 ng/ml 4963 ng/ml 5343 ng/ml 
% precipitation 0% 0% 0% 1% -7% 


















concentration 38 mg/ml 20 mg/ml 15 mg/ml 10 mg/ml 5 mg/ml 
Measured 
concentration in 
supernatant 1241 ng/ml 2585 ng/ml 2943 ng/ml 5329 ng/ml 5965 ng/ml 
% precipitation  75% 48% 41% -7% -19% 
 
HPLC analysis resulted in concentrations of dFdC in the supernatant close to the theoretically expected 
value for all salts except for Ammonium phosphate. As the HPLC-results also showed, the solubility of 
dFdC in a solution of ammonium phosphate (dibasic) seemed to decrease as the concentration of the 
dFdC decreased. If the reason for the not solving dFdC was binding to the phosphate in the salt this 
process would have been expected to be slow, so that we first got dissolved dFdC, and then later a 
precipitation. Also if this were the mechanism we would not have expected a so rapid decrease in 
precipitation with lower concentrations of the dFdC.  
To look further into this the pH-values of the different solutions were measured. It was revealed that 
the salt ammonium phosphate (dibasic) had a high pH, of 8.18, while the other salts ranged from 5.5 
and below. It is expected that dFdC is less soluble at higher pH. This is because at higher pH-values a 
smaller fraction of dFdC is charged, thereby making it less soluble. Though a binding of dFdC and 




To investigate the findings in experiment 3 further I made solutions of potassium dihydrogen phosphate, 
ranging from 25 to 120mM. The pH of the solution was adjusted to 7 by drop-wise adding NaOH or 
HCl. The dFdC concentration was 38mg/ml (114mM), and was achieved by weighing the dFdC-
powder directly into reaction-tubes, as in experiment 3, then adding the pH adjusted salt (because lack 
of small enough pH-meter to measure pH in reaction tubes  at the time the pH in the final solution was 
not measured). To have something to compare with I made a sample were I simply mixed water and 
dFdC (no precipitation is expected to happen in water). The samples were stored in the fridge over 
night, then centrifuged and diluted as in experiment 3. The results can be seen in the table below. 
Table 13: Precipitation of dFdC when increasing concentration of potassium dihydrogen 
phosphate. Measurements done on HPLC.  
Concentrations of potassium 
dihydrogen phosphate % precipitated
25mM  14%
50 mM  19%
120 mM  55%
As can be seen the fraction precipitated dFdC increased with increasing amount of potassium phosphate 
concentration. 
Experiment 5 
In the next step, the pH of all the salts-solutions used in experiment 3 was adjusted to 7 by adding drops 
of NaOH or HCl –solutions of 1 and 0.5 M respectively. In addition to the salts, which had been used in 
experiment 3, two other salts were included; di-sodium hydrogen phosphate dihydrate and Potassium 
dihydrogen phosphate, both in concentrations of 120mM and pH adjusted to 7. A solution of the 
desired salt and a dFdC solution of 3mg/ml were mixed together, giving a final concentration of 19 
mg/ml dFdC (72mM), and 60mM of the desired salt. Samples were placed in the fridge (about 60C) 
over night (about 18h). Samples were observed, then centrifuged and an aliquot of the supernatant 
diluted to a theoretical concentration of 5μg/ml prior to measuring by HPLC. The results can be seen 
in the table below. 
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Table 14: Observed and measured precipitation in solution with a dFdC concentration of 
19mg/ml (72mM), and a 60 mM concentration of different salts. pH in the salt-







Control sample (no precipitation) 0% no 
Sodium bisulphate anhydrous 45% yes 
Ammonium sulphate 12% no 
Ammonium phosphate (monobasic) 47% yes 
Ammonium phosphate (dibasic) 53% yes 
Sodium dihydrogen phosphate (monobasic) 60% yes 
Ammonium hydrogen sulphate 8% no 
di-sodium hydrogen phosphate dihydrate 76% yes 
Potassium dihydrogen phosphate 44% yes 
 
The results showed precipitation with all salts, but with great variations between the different salt-
solutions. There also seemed to be not so big difference between the sulphate and phosphate salts, 
although altogether phosphate salts seemed to generate more precipitate. Though we had no real 
explanation for the variations between each individual salt type. 
Experiment 6 
The theory was still that there were a binding between the sulphate or phosphate salt and dFdC that 
created the precipitation. It was discussed that maybe the binding of the dFdC(+) and the 
phosphate/sulphate(-) could happen faster at a lower pH then 7, because the lower the pH the more 
dFdC would be charged. On the other hand a high pH for the salt would make more of it charged, so I 
had to find a point were they both could interact and form precipitation rapidly. 
It was decided to go further with 2 salts from the previous experiment, one sulphate salt and one 
phosphate salt, and test them at different concentrations. Ammonium sulphate was chosen as the 
sulphate salt and ammonium phosphate dihydrate was chosen as the phosphate salt. The salts were 
mixed with dFdC to form a final dFdC concentration of 19mg/ml, and a salt concentration of 240, 120, 
60 and 30 mM. Tree parallels of each pH and salt was made. One parallel was stored for 2 hours at 
500C in a in an oven, then one hour in the fridge. One parallel was stored in the fridge for 2 hours, at 
about 60C. One parallel was stored in room temperature for 2 hours. They were all compared to a 
control sample that had been stored similarly, but only containing water and dFdC. They were then 
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centrifuged and diluted as in the other experiments. 
For the samples where dFdC was mixed with a salt at pH 4 there were no visible or measurable 
precipitation. For the pH 7-salt-mixtures there were only visible precipitation with ammonium 
phosphate dihydrate 240 and 120 mM, and only the samples that had been stored in the fridge. The 
quantitatively measurements of precipitation in the "pH 7"-salts can be seen in the table below.  
Table 15: Measured precipitation on HPLC of different salt-solutions, concentrations and 
storing conditions.  
 Salt and concentration 
Stored in 
fridge for 2h 
(60C) 
Stored in room 
temp 2h (200C) 
Oven for 2h (500C), 
then 1h fridge 
Ammonium sulphate:       
240 mM -7% 6% 1% 
120 mM -6% -11% 2% 
60 mM 0% -4% 5% 
30 mM 4% -10% 0% 
Ammonium phosphate (dibasic):       
240 mM 39% 6% -2% 
120 mM 49% 11% 0% 
60 mM 6% -4% 3% 
30 mM 1% -5% 0% 
 
A few days later I was able to get my hands on a small enough pH-meter to measure pH-values in very 
small amounts of solutions, like the ones I had in this experiments. When using it to measure the pH in 
the solutions that were tested I saw that the pH was far lower than what I was expecting. Ammonium 
phosphate (dibasic) seemed to have the best buffer capacity, and was least affected by the adding of the 
acidic dFdC-solution. The pH of the solutions of salt and dFdC that was supposed to be 7 can be seen in 
the table below: 
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Table 16: pH measured on mixtures of a salt of pH 7 and dFdC. 







Oven + fridge 
samples 
Ammonium sulphate:       
240 mM 3.2 3.2 3.2 
120 mM 3.2 3.2 3.2 
60 mM 3.0 3 3.0 
30 mM 3.0 3 2.9 
Ammonium phosphate (dibasic):       
240 mM 6.1 6 6.0 
120 mM 5.6 5.6 5.6 
60 mM 3.8 3.8 4.0 
30 mM 3.3 3.3 3.2 
Control sample (water, no pH 
adjustment): 2.7 2.7 2.7 
The adding of the solution of gemcitabine had clearly influenced the pH of the different solutions. This 
also led me to the conclusion that the pH might have been more important than the type of salt used in 
the solution.  
Experiment 7, pH adjusted solutions 
The same salts were used as in last experiment, at a final concentration of 240mM. The final 
concentration of dFdC was 19mg/ml. But since the pH was adjusted after the mixing the real 
concentration of dFdC and salt would actually be slightly lower, and also varied a bit from vial to vial. 
To know the exact concentration at all time the reaction tubes were weight on a balance before and 
after the adjustment. This was then taken into consideration in the further dilutions. The problem with 
this approach though was that the concentrations of dFdC vary a bit, and that may in some cases make it 
hard to distinguish if the precipitation was because of the pH or the dFdC concentration.  
As a check to see if it was the pH alone leading to the precipitation I also prepared a sample of dFdC and 
water, which I tried to pH-adjust to about 7, adding sodium hydroxide or hydrochloric acid. The results 
can bee seen in the table below. 
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Table 17: % precipitation of dFdC in pH adjusted solutions, which had stayed one night in 
the fridge. 











Ammonium phosphate (dibasic):       
2 1.9 2.1 no 45% 14.6 mg/ml
4 3.9 4.6 no 7% 10.7 mg/ml
5 5.1 5.3 no 8% 9.9 mg/ml
6 5.9 6 yes 72% 16.6 mg/ml
7 7 7.2 yes 62% 16.9 mg/ml
8 8.2 8.6 yes 54% 14.3 mg/ml
Ammonium sulphate:         
6 5.4 5.4 no -52% 8.1 mg/ml
7 7 7.2 yes 68% 11.9 mg/ml
Water:           
~7, (though water has 
no buffer capacity) 7.2 4.4 yes 51% 12.9 mg/ml
Control, pH not 
adjusted… 2.7 2.7 no 0% 19.0 mg/ml
 
The results represent just one parallel, and the differences seen should therefore not be interpretated to 
much by it self. Nevertheless it is pretty clear that the pH is important for the precipitation. Also one 
surprising thing that clearly goes against the salt binding theory for the precipitation is that dFdC in a 
solution of pH-adjusted water also precipitated. This was necessary to investigate further. 
Further parallels 
Firstly I made 2 more parallels, parallel 2 and 3, in the similar way. Then, since some of the results was 
a bit unclear I made parallel 4. The results can be found in the table below. 
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Table 18: Precipitation at different pHs, in overnight samples, up to 4 parallels. Parallel 1, 
pH 5 was removed, as it differs much from the rest of the measurements. 
Target % Precipitation, all parallels     Standard 
Precipitated 
- standard 
pH # 1 # 2 # 3 #4 Average deviation deviation 
Ammonium phosphate 
(dibasic)           
2 45% -16% 8%   12% 25% -13%
4 7% -20% 22%   3% 17% -14%
5 (8%) 40% 49% 57% 49% 7% 42%
6 72% 50% 52%
 
62% 59% 9% 50%
7 62% 55% 49% 53% 55% 5% 50%
8 54% 50% 39% 50% 48% 6% 43%
Water               
6 - 46% 20%   33% 19% 14%
07 / 08 51% 40% 39%   43% 5% 38%
Control 
sample 0% 0% 0% 0% 0% 0% 0%
 
Putting the numbers into a diagram gives the figure below. In the table above and the figure below 
parallel 1, pH 5 was ignored because it differed significantly from the rest of the numbers obtained. 
That could maybe also have been done with parallel 1, pH 6, though the standard deviation of pH 6, 7 
and 8 would still have crossed each other. One explanation for this big standard deviations may be that 
the parallels, except parallel 2 and 3, was carried out on different days, and that conditions such as 
fridge temperature, time in fridge or handling may have varied slightly from day to day. There seems to 
be a correlation within each parallel of which pH gives the best precipitation. pH 6 for example is the 




























































Figure 6.6. % precipitated dFdC in different pH's in solution of ammonium phosphate (dibasic) (APD) or 
water 
Something else that might be the cause of the variations in precipitation between pH 5, 6, 7 and 8-
samples might have been the concentration of the dFdC. The solutions with pH 6 and 7 had an average 
of 17.0 and 17.6 mg/ml respectively, while the pH 5 and pH 8 solutions had an average of 15.9 and 
15.4 respectively (not counting pH 5 parallel 1). This problem could have been avoided first adjusting 
the pH, then fill up the sample with water so that all the samples had the same concentration of dFdC. 
Crystal shape and differences 
Though pH-adjusted water also gave precipitation it was not as high as the precipitation at similar pH in 
ammonium phosphate (dibasic). This could be caused by the low buffer-capacity of the water, for 
instance a sample of water and dFdC that was adjusted to a pH of about 7 was measured to pH 4.4 the 
next day. But it could also mean that there was a precipitation because of pH, but that it in addition was 
a binding of ammonium phosphate (dibasic) and dFdC. If this was the case this might have created 
different forms of crystals. 
To investigate this I extracted some precipitated dFdC from the parallel 1 samples, and looked at them 




Figure 6.7. Investigation of dFdC-crystals in microscope. On the left side: Water and dFdC, pH 7. On the 
right side: ammonium phosphate (dibasic) and dFdC, pH 7.  
 
Figure 6.8. Investigation of dFdC-crystals in microscope. On the left side: ammonium sulphate and dFdC, 
pH 7. On the right side: ammonium phosphate (dibasic) and dFdC, pH 8.  
The pictures differ slightly, and might lead you to think that it is a difference. But the crystals are mainly 
rod-formed, and of equal size. The difference is the spot in the sample were the picture is taken. By 
studying the samples carefully in the microscope I came to the conclusion that there were no visible 
differences that would indicate that any of the samples had an other kind of crystals than the rest.  
Experiment 7, room temperature experiment 
All the experiments above were carried out in the fridge. Both to get an idea of the stability of the 
precipitated dFdC, and as a possible approach to loading, there was decided that I should test the 
achieved precipitation at room temperature. The pH in 4 parallel vials containing dFdC and ammonium 
phosphate (APD) was adjusted to 6.5 (+/-0.2). The vials were then filled up with distilled water so that 
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the concentration of dFdC in all vials was 15.83 mg/ml. The vials were stored in the fridge over the 
weekend (about 70 hours), before samples of the supernatant were diluted to a theoretical 
concentration of 5.0 μg/ml and analyzed by HPLC. To determine the amount of dFdC that had 
precipitated the concentration of dFdC in the supernatant were compared with a control sample (a 
sample that had gone through the same conditions, but only containing dFdC and water, and therefore 
was expected not to precipitate).  
The result was a average of 32% (+/- 2.7%), so a little bit lower that the results from the "fridge-
samples". All vials had visible precipitation on inspection, but on the measuring on HPLC parallel 
number 4 showed a precipitation of only 2%. Parallel 4 was of this reason ignored. The results can bee 
seen in the table below.  
Table 19: Measurements of precipitated dFdC in solutions of 120 mM ammonium 
phosphate (dibasic) (APD), pH 6.5. The value of parallel 4 differed significantly 
from the other numbers, and was therefore ignored. 
Salt and pH % precipitated   
#1 APD pH 6.5 30% Average (not parallel 4): 32% 
#2 APD pH 6.5 31% Standard deviation (not parallel 4) 2.7% 
#3 APD pH 6.5 35%   
#4 APD pH 6.5 
 
2%   
Control (H2O) 0%   
 
Experiment 8, test of precipitation in different solutions 
The results from experiment 6 gave a strong indication that the precipitation of dFdC was not a result of 
a binding to a salt, but rather a result from the pH in the solution. The only thing that might indicate 
something else is that the precipitation in pure  water was generally lower than the other solutions. My 
theory was that this was the result of the low buffer-capacity in the water-dFdC-solution. To investigate 
this further I made an experiment making solutions of dFdC and 120mM of either ammonium 
phosphate (dibasic) or sodium bisulphate anhydrous, or 25mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), 3 parallels of each solution. The pH was adjusted, and the solutions 
were further diluted to a concentration of 10.36 mg/ml dFdC. Samples were stored in fridge (~60C) 
over night (18 h). The samples were then investigated, centrifuged, and parts of the supernatant was 
extracted and investigated further. The results and can bee seen in the table and figure below. 
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Table 20: Precipitation of dFdC in solutions of different salts and concentrations, pH 
adjusted to 6.5. 




(dibasic) 120mM 35% 38% 32% 35% 2%
Sodium bisulphate 
anhydrous 120mM 45% 28% 39% 37% 7%
HEPES 25mM 24% 31% 36% 31% 5%



























Figure 6.9. % precipitated dFdC in different pH's in solution of ammonium phosphate (dibasic) (APD) or 
water 
As all the standard deviations overlap there were no significant difference between the types of salt used 
in the solutions. This is another indication for that the precipitation is a result of pH alone, and not 
related to the type of salt used in the solution. 
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Experiment 9, test of the effect of pH when concentration of dFdC is constant 
Experiment 7 indicated that there might be an optimal pH-region for precipitation at around pH 6-7 
(though not significantly better than pH 8). But the results might be biased by the fact that the pH 5 and 
pH 8 samples generally were more diluted than the pH 6 and pH 7 samples. Therefore I made one more 
experiment varying the pH'es. Solutions of 120 mM ammonium phosphate (dibasic) and 16mg/ml 
dFdC were made in the same way as experiment 8. pH'es ranged from 4 to 8, in addition to two 
control-solutions containing only dFdC and water. Because of the costs of dFdC, and because we 
already had the results from experiment 7, there were only made one parallel. Samples were stored in 
the fridge (about 50C) over night (19 h), then centrifuged and supernatant were extracted as usual. 
Precipitation was observed in all samples except the two control samples. The results can bee seen in 
the table below: 
Table 21: Precipitation of dFdC in solutions Ammonium phosphate (dibasic) 120mM and 
16mg/ml dFdC, varying pHs. 
Target pH 4 5 6 7 8 
% precipitated 
dFdC 36% 29% 44% 42% 35% 
 
The results continue to back up the previous results, that pH 6 and 7 gave higher precipitation than both 
pH 5 and pH 8 solutions. But the precipitation at pH 4, combined with the fact that pH 4 gave higher 
precipitation than pH 5 and that there were only one parallel at each pH contributes to create doubt 
around the result. But at least the precipitation at pH 4 can be explained by the fact that the 
temperature in the fridge was measured to about 10C colder than in the previous experiments.  
Experiment 10, stability of the precipitated dFdC 
In order to load the dFdC into liposomes heating/freezing cycles could be one approach. Without 
heating the liposomes, the crossing of the liposome membrane is believed to take significantly longer 
time. With the help of heating/cooling cycles it would be possible to let the liposomes passively load, 
then cool them down to let the dFdC inside precipitate, then heat the solution up again so that more 
dFdC can passively load into the liposomes. Though for this approach to become more than just 
passively loading it is dependent on that the dFdC inside the liposomes don't dissolve again as soon as it 
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is heated up. Therefore it was necessary to take a look at the stability of the precipitate from the 
liposomes. 
Small preliminary tests without quantification 
Firstly I did some small tests with some precipitated samples, which I only inspected visually. Samples 
were placed on a water bath, and inspected visually after a certain amount of time. RPM on the water 
bath was set to 50. For times under one hour it seemed like at least not all the precipitated dFdC did 
dissolve at temperatures under 400C. One new experiment at 45 and 550C also showed that not all of 
the precipitated dFdC did dissolve within an hour on the water bath. Also 600C for 40 minutes did not 
dissolve all precipitated dFdC (it did not dissolve after 40 minutes either, but the experiment were 
terminated). 
But this experiment only shows what we already knew, that the precipitated dFdC is hard to dissolve. 
What we needed to know was how hard it was to dissolve, in addition to how much dFdC dissolves 
after a certain amount of time. 
Quantifying dissolution-rate of precipitated dFdC at elevated temperatures for one hour 
For this experiment I used samples from experiment 8, "test of precipitation in different solutions". 
The pH of the salts used were 6.5, and the salt used was 120 mM ammonium phosphate. Before this test 
the samples had stayed in the fridge for 2 days. The experiment was set up to take out 50μL of sample 
every 15 minute, to measure if more dFdC had been dissolved after a certain time period. Theoretically 
withdrawing aliquots from the reaction tube would not affect the concentration of dFdC being dissolved 
in the solution, as this is dependent on the solubility product and velocity of the dFdC to dissolve. For 
comparison, one reaction tube sample was placed in an oven, while one were placed on a water bath at 
100rpm. Temperature in both places was set to 600C. 
All samples were diluted to a theoretical concentration of 6μg/ml, prior to analysis on HPLC. The 




Table 22: Estimated precipitated content left in reaction tube, based on analyses of the 
supernatant. Incubation temperature is 600C. 
  Estimated precipitated amount left (%) 











0 44% 4% 45% -4%
15 46%   43%   
30 44% 0% 45% 8%
45 38%   37%   
60 39% -5% 41% -4%
Average 0%   0%
Standard deviation 4%   6%
 
As these results showed, some dFdC did dissolve though the increase were not that high after 1 hour. 
Also, the last measurement shows a slightly increase of not dissolved dFdC. Therefore this was needed 
to be investigated further.  
Quantifying dissolution-rate of precipitated dFdC at elevated temperatures for two hours 
For this experiment I used the samples from experiment 9, "test of the effect of pH when concentration 
of dFdC is constant". Both samples, and the control sample, had stayed in the fridge over the weekend. 
Except that the experiment was carried out during a longer period of time, the rest were as last time. 
Results can bee seen in table below. 
Table 23: Estimated precipitated content left in reaction tube, based on analyses of the 
supernatant. Temperature is 600C. 
  Estimated precipitated amount left (%) 















0 40% Yes 0% 43% Yes 0%
30 37% Yes   42% Yes   
60 27% Yes 1% 41% Yes 1%
90 22% No   35% Yes   
120 18% No -3% 8% No 4%
Average -1% Average 2%





Careful considerations are necessary when analyzing these results. Especially when using them to plan 
how to load liposomes. Except for the fact that there are few parallels, and that samples from earlyer 
experiments were used, one of the biggest problems with this study is the size of the precipitated dFdC-
crystals, which beforehand had been centrifuged to the bottom of the reaction tube. It was for example 
observed that when heating precipitated dFdC the first thing to disappear were the small crystals on the 
walls of the reaction tube. So one should probably be careful transferring these findings directly to what 
would happen in liposomes. 
Experiment 10, speed of precipitation, fridge compared to ice 
In this experiment I would measure how fast precipitation occurred under different conditions. What I 
wanted to measure was how fast the precipitation occurred in the fridge (measured to 5.70C that day) 
compared to an ice bath (which will be close to 00C all the time). Solutions of 120 mM ammonium 
phosphate (dibasic) and 19mg/ml dFdC were made. pH was then adjusted to 6.5, and dFdC 
concentration to 14.6μg/ml in all vials. One sample of 50μL was extracted every hour for 3 hours. It 
was then centrifuged and diluted as in the other experiments. The results can bee seen in the table 
below: 
Table 24: Precipitation by dFdC hour by hour, fridge compared to ice. 
  Precipitation 
Sample type 1 hour 2 hour 3 hour 
Fridge, APD pH 6.5, #1 62% 59% 66%
Fridge, APD pH 6.5, #2 59% 59% 66%
Fridge, APD pH 6.5, #3* 5% 37% 52%
Fridge, H2O (Control) -1% -4% 5%
Avarage (excl. control) 42% 52% 61%
Standard deviation (excl 
control) 26% 10% 6%
Ice, APD pH 6.5, #1 69% 79% 83%
Ice, APD pH 6.5, #2 43% 63% 71%
Ice, APD pH 6.5, #3 59% 36% 80%
Ice, H2O 29% 73% 28%
Avarage (excl. control) 57% 59% 78%
Standard deviation (excl. 
control) 10% 17% 5%
   
As seen in the table above also control sample of dFdC on ice precipitated. Though it was measured 
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both at hour 1, 2 and 3, it was only visible at hour 2, and then it disappeared. As 29% precipitation also 
would have been visible the measurements of the ice control sample after 1 and 3 hours can be assumed 
to be false positives, reasons unknown. The precipitation after 2 hours on the other hand was visible. It 
therefore seems that dFdC can precipitate at very low temperatures even if the pH is low, though at low 
pH it also seems to dissolve easily. On the other hand this seems to hint that the temperature on the 
icebath was not stable, as it is expected to be, and questions the reliability of the results. Just for the 
record, all the precipitations were calculated against the control sample from the fridge.  
6.3.3 4th set of experiments; using precipitation as an instrument to load 
liposomes. 
The results from the 3rd sets of experiments were not the ones we had been hoping fore. The 
mechanism behind the precipitation seems to bee dFdC's low solubility at higher pHes, rather than 
complex forming with another salt such as the phosphate salt. Even on ice, with a concentration of 
14.6μg/ml dFdC, the precipitation was not higher than 83% (+/-5%) after 3 hours. To make dFdC 
load via this method a high pH inside the liposomes is needed for precipitation to take place, while pH 
on the outside should be much lower so to avoid precipitation there. This is the total opposite of the 
active loading via an ammonium sulphate gradient described in section 3.3, active loading. As known 
from this section a significant amounts dFdC will get charged at low pHes, and charged dFdC does not 
cross liposomes membranes. This might then cause an effect, that I choose to call reverse loading, 
where gemcitabine get charged on the outside of the liposomes and therefore will not pass the 
membrane to the inside. To prevent this reverse loading the external pH must be low enough for 
precipitation not to take place (or at least so high that it easily redissolves on light heating), but high 
enough to prevent reverse loading. And also even though the heating experiments with dFdC showed 
good stability of precipitated dFdC the same might not be the case in liposomes. In short there were lots 
of uncertainties to this way of loading gemcitabine into liposomes, and the only thing I could do was to 
make a professional guess, then test if it worked. 
Experiment 1, two weeks loading in cold-room 
It was decided to first try loading in very low temperatures, since the precipitation was seen to be 
highest here. Hilde Gravem had shown that loading in room temperature for over 24 hours gave 
comparable results to room temperature for1 hour followed by heating for 2 hours (Gravem 2006). 
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The plan was to load the liposomes in a cold-room expected to be around ~50C. Becouse this was 
significantly colder than what Gravem used it was decided to load them for a significantly longer period; 
two weeks.  
As mentioned in the introduction to this section I no longer try to load the liposomes as described in 
section 3.3, active loading, where ionization of the gemcitabine on the inside of the liposomes is the 
reason for entrapment. What I want to do here is to make gemcitabine precipitate inside the liposomes, 
and as found in the 3rd sets of experiments this is archived by a high pH. As pH 6 and 7 had shown to 
give the best precipitation (all though not significantly better than pH 8), I decided to use a pH of 6.5 as 
the inner pH. To buffer the solution I used ammonium phosphate (dibasic) (APD), because I by my 
experience with it during the precipitation experiments observed that its buffer capacity was very good. 
As outer pH I made one parallel with pH around 3 and another parallel with pH around 4 to see which 
of them gave the best loading.  
The VPGs were prepared similar to the 2nd sets of experiments, with batches of 1000 mg VPGs, 
containing 35% lipids, and 65% of 240mM APD, pH 6.5. In advance I had experimented with how to 
mix the liquids to get the desired pH in the outer phase of the liposomes. The VPGs that were going to 
have the pH 4 in the outer phase I diluted 1/3 with more 240 ammonium phosphate (dibasic), divided 
them into 4 parallels, and diluted them 1/2 with a solution of 38mg/ml dFdC in water. The liposome 
batch which was going to have an outer pH of 3 I diluted 1/3 with 240 mM ammonium phosphate 
(dibasic) pH 4, then divided them into 4 parallels and diluted them 1/2 with a solution of 38mg/ml 
dFdC in water. The pH in each liposome batch was then measured, and the results can be seen in table 
below: 
Table 25: pH of the outer phase of the liposome batches. 
Parallel: #1 #2 #3 #4 
Target: pH 
4 3.98 4.1 3.91 4.07
     
Parallel: #1 #2 #3 #4 
Target: pH 
3 3.31 3.23 3.17 3.19
 
As seen the pH 4 hit quite well, while the batches targeted pH 3 got a little too high. That did not 




The samples were then placed in the cooling room for 2 weeks. So that the liposomes would not 
sediment the reaction tubes were placed on a shaking machine at 50 RPM. 
After the two weeks aliquots of the liposome samples were withdrawn and applied on cation exchange-
columns to separate the free dFdC in the solution from the entrapped. This samples I choose to call 
"loaded samples", while the samples that did not undergo cation exchange, thus containing both free 
and entrapped dFdC, I choose to call 100% samples. Both the loaded samples and the 100% samples 
were cracked with triton-X, and then diluted to a theoretical concentration of 6μg/ml before being 
applied on HPLC. 
PCS results 
PCS-measurements were taken of the liposomes with dFdC before and after the 2 weeks. The values 
may indicate that there has been a change in the size-distribution of the liposomes within the two weeks. 
The mean diameter of the samples were unusually high before the two weeks in the fridge, while it 
seems like it had been reduced afterwards, at least in the pH 4 sample. 
Table 26: PCS-results, outer phase pH 4, right after production 
  
Channel width 27 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 100.7 108.4 103.6 104.3 123.4 124.9 180.5 189.9
Variance (P.I) 0.249 0.23 0.249 0.253 0.226 0.223 0.118 0.1
Chi squared 10 18 4 4 0.394 0.895 0.893 1
 
Table 27: PCS-results, outer phase pH 3, right after production 
  
Channel width 
88.0 (auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 336.7 334.1 90.9 92.8 81.5 81.5 80.1 69.3
Variance (P.I) 0.48 0.524 1 1 1,232 1 0.64 0.748




Table 28: PCS-results, outer phase pH 4, after 2 weeks 
  
Channel width 44.0 
(auto) 
Channel width 
20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 95.3 93.6 65.6 65.7 58.6 58.6 57.4 57.8
Variance (P.I) 0.548 0.573 0.803 0.808 0.799 0.797 0.656 0.646
Chi squared 82.485 188.352 5.172 10.207 0.568 0.966 1.165 1.242
 
Table 29: PCS-results, outer phase pH 3, after 2 weeks 
  
Channel width 50 
(auto) 
Channel width 
20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 118.0 116.7 77.5 77.6 84.7 83.5 141.5 155.5
Variance (P.I) 0.564 0.587 0.841 0.843 0.702 0.706 0.361 0.329
Chi squared 118.067 256.439 0.457 0.439 0.739 0.891 0.976 1.238
 
Temperatures 
The temperature in the room was measured with an electronic thermometer to keep track of any big 
changes in temperature during these two weeks. One measurement was preformed every hour, and 
there were 411 measurements in total. The maximum temperature was 13.400C, the minimum 4.300C, 
and average was 6.550C. A graphical description of the temperature-variations during the two weeks 





Figure 6.10. Temperature in the cold-room during the two weeks of experiment. 
dFdC values 
The dFdC values showed no loading, but the rest of the samples were in the expected range. Control 
samples were blank. The results can bee seen in the tables below: 











concentration 6000 6000 6000 6000
Measured 
concentration 0 0 0 0











concentration 6000 6000 6000 6000
Measured 















concentration 6000 6000 6000 6000
Measured 
concentration 4295 7327 4297 5133











concentration 6000 6000 6000 6000
Measured 
concentration 3435 3204 4467 3189
 
Cholesterol value 
Cholesterol values were mostly in the expected range, though there were some smaller variations. The 
results can bee seen in the tables below: 










Theoretical concentration 138.6 138.6 138.6 138.6 
Measured concentration 167 146 97 105 
"Loss" of cholesterol: -17% -18% 18% 43% 










Theoretical concentration 138.6 138.6 138.6 138.6 
Measured concentration 108 149 140 140 















concentration 138.6 138.6 138.6 138.6 
Measured 
concentration 145 126 175 170 











concentration 138.6 138.6 138.6 138.6 
Measured 
concentration 157 189 180 195 
 
Discussion 
There were no detectable loading of the dFdC. As mentioned under the discussion of the 2nd sets of 
experiments when diluting the samples to a theoretical concentration of 6μg/ml we should be able to 
detect loading efficiencies as low as 1.7% (and even lower) at the HPLC. 
Maximum theoretical loading 
Even though we did not use size extrusion chromatography to get rid of any ions, the liposomes was 
diluted to some extent before loading. We can assume the VPGs entrapped 40% of the water content in 
the solution. The VPG's were then diluted 1/3, and then 1/2 again when adding the dFdC-solution. 
That would result in 6.67% of the total water content being inside the liposomes, hence if there were 
only passive loading it would be expected to be in that range. Therefore this can not be the only 
explanation for the bad loading. 
Osmolarity 
One issue is that the osmolarity were not taken into consideration when mixing the dFdC and the 
liposomes; the dFdC powder was dissolved in water, not NaCl. Also the concentration of ammonium 
phosphate (dibasic) was considerably over the osmolarity of 0.9% NaCl (see calculations on isotonicity 
in appendix 2). Theoretically this would crate a hypotonic environment, causing liposomes to swell and 





There can be discussed if any dFdC passed the membrane of the liposomes at such low temperatures. 
Even though the period of time was quite long this might not have been enough for the dFdC to cross 
the membrane. 
Other factors 
As discussed in the start of this experiment there is a chance that we get a "reverse loading" effect, 
where dFdC get charged in the outside of the liposomes, and therefore less dFdC passes the membrane. 
Even at pH 4 a significant amount of dFdC, 38%, will be charged. Precipitation is also a lot slower 
process. 
Also it is known that nucleoside analogues such as gemcitabine may cause hydrolysis of liposomal 
phospholipids (Moog, Brandl et al. 2000). As this was a quite long experiment lasting for 2 weeks 
hydrolysis would have plenty of time to occur, and may also have been a contributing factor to the 
result.  
Experiment 2, loading with heating cooling cycles 
Procedure 
With the experience gained from experiment 1 and the 3rd sets of experiments I tried to set up an 
experiment with heating cooling cycles that was likely to give a high loading. To have exact and 
reproducible temperatures a water bath was used for the heating, while the cooling found place on an 
ice bath (expected temperature of 00C). The cycles were set up in the following 6 steps: 
1. Heating in water bath at 600C for 2 hours 
2. Cooling on ice for 3 hours 
3. Heating at 600C for 30 minutes.  
4. Cooling on ice for 2 hours 
5. Heating at 600C for 30 minutes 
6. Cooling on ice for 2 hours 
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The heating at step 1 was so that dFdC could pass the liposome membrane easily. Since there is nothing 
entrapping dFdC inside the liposomes the loading in this process is expected to be equal or less than 
passive loading (less because of the "reverse loading" effect previously mentioned). This was followed 
by step 2, a long cooling-time so that all dFdC already inside the liposomes could precipitate. The 30 
minutes at 600C in step 3 was a compromise between wanting more dFdC to enter the liposomes while 
hopefully not solving the already entrapped dFdC. The heating-experiments of dFdC precipitated dFdC 
showed in the 3rd set of experiments the dissolving of the precipitate happened gradually and took over 
an hour to dissolve completely (thought we did not know if the same would be the case inside 
liposomes). 
This loading depended on that a large amount of dFdC inside the liposomes would precipitate during 
the cooling cycles. New dFdC would also have to enter the liposomes every time we heated up the 
solution, while little of the precipitated dFdC would dissolve. According to this theory the last step was 
a little bit unnecessary as no loading occurs between step 5 and step 6, just precipitation of dFdC 
already inside (for more dFdC to be loaded new dFdC has to enter). But in total there should be 3 
loading cycles were more dFdC get into the liposomes. 
The pH on the inside of the liposomes was decided to be 7. This was mainly because good precipitation 
were seen on this and surrounding pH, but also because that the lyso-transformation of EPC-3 
liposomes showed some of the lowest lyso-transformation at this pH (Moog, Brandl et al. 2000). The 
outer pH was set to 4. These were a compromise between trying to avoiding precipitation on the 
outside of the liposomes, and at the same time reduce the extent of the "reverse loading".  
To buffer the solution both on the inside and outside of the liposomes a solution with 133 mM 
ammonium phosphate (dibasic) was used. This concentration was calculated to be isoosmotic to 0.9% 
NaCl (see appendix 2). The solution of dFdC, containing 38mg/ml dFdC also consisted of 0.9% NaCl. 
Since most of the previous experiments on precipitation were at around 16μg/ml dFdC, used the same 
concentration in this experiment.  
1000mg liposomes were made according to procedure, and then diluted with 1263μL 38mg/ml dFdC 
in 0.9% NaCl, and 737μL ammonium phosphate (dibasic) pH7. To try to find how to make the outer 
pH 4 I made a "simulation" of the amounts of dFdC that I was going to use. When mixing the solutions 
in the ratio mentioned above, simulating the inner phase by using only half of the solution, I measured a 
pH of 4.08, and that was the reason for the mixing regime I used. Also in this mixture of liposomes the 
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liposomes were not diluted so much as in previous experiments. If the inner water phase was 40% at 
start, the VPGs are only diluted ones, 1/3, and the inner water phase should be about 13 % (and so 
passive loading would be expected to be in that range). The liposomes were divided into 2 parallels of 
600μL each.(Learned from the previous experiments I had seen that it were often smart to test a few 
parallels first to see if they work, then run a full size experiment) 
I was making several withdrawals of the liposome dilutions at different times in the loading process, 
totally 6 times, extracting 50μL each time. This was to keep track of the course of the loading-process. 
The reaction tubes were vortexed before each extraction so that the lipid content extracted each time 
would be the same. Therefore the extraction would not interfere with the ratio of inner and outer 
dFdC. 
After each extraction of samples they were diluted 1/10 in 0.9% NaCl, before free dFdC were 
removed by ion exchange. All samples were cracked with triton-x, and then diluted to a theoretical 
concentration of 6μg/ml prior to HPLC. 
Because of lack of time in addition to a big worldwide shortage of acetonitrile, the cholesterol values 
were not measured. In most of the previous experiments the cholesterol values had been in the 
expected range, and they had not given much value to the previous experiments anyway.  
First pare of parallels 
Samples were taken after step 1 (heating, passive loading), step 2 (1. cooling), after step 4 (2. cooling), 
after step 5 (3. heating), and after step 6. Actually there was no reason for taking a sample at step 2, as 
only precipitation, not loading had occurred. Samples taken at step 5 and step 6 should also have about 
the same value. 
Measurements for PCS were taken of the liposomes before the first heating and after the first cooling, 
the last sample to see if the cooling might have destroyed the liposomes in some way (for example by 
crystal forming dFdC). The PCS-results looked normal and in range, and there did not seem like any 
mayor differences between the first and second measurement, except maybe some strange values at the 
auto channel width in the first PCS-results (see below). The reason for this might be some very large 
liposomes in the first measurement. 
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Table 34: PCS-result before step 1 
  
Channel width 60 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 124.9 122.6 65.8 65.2 55.7 56.2 51.3 51.6
Variance (P.I) 0.679 0.697 1.020 1.006 0.974 0.939 0.753 0.745
Chi squared 480.941 948.582 9.607 16.560 0.980 1.258 0.925 0.985
Table 35: PCS-result after step 2 (cooling) 
  
Channel width  31 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 76.1 73.9 62.3 60.6 60.8 59.9 63.6 64.3
Variance (P.I) 0.434 0.456 0.552 0.560 0.530 0.539 0.460 0.454
Chi squared 1.551 7.286 2.698 1.976 0.466 0.463 0.777 0.851
 
First results of the loaded samples gave some very small tops indicating concentrations of about 
300ng/ml. New dilutions were made with a theoretical concentration of 12μg/ml to get more accurate 
measurements. Now the values ranged around 700ng/ml. The aria under the curve of the samples were 
divided in half, and then divided on the aria under the curve from the 100% samples to get the loading 
%. Results can bee seen in table below: 
Table 36: Lading efficiencies in the samples after freezing-cooling cycles 
 
After 1. step, heating 
(passive loading) 
After 2. step, cooling  
(still passive loading) After 4. step, cooling 
Parallel 1# 2# 1# 2# 1# 2# 
Loading 
efficiency 5.1% 4.4% 4.4% 4.7% 4.4% 5.7%
       
 After 5. step, heating 
After 6. step, cooling  
(should not be any different 
from last sample)   
Parallel 1# 2# 1# 2#   
Loading 
efficiency 5.3% 6.2% 5.9% 5.6%   
 
It is not possible to interpret if an active loading had occurred, or if this is just random variations. 
Dough there is a slight increase in detected dFdC in the loaded samples the increase is to small, and the 
parallels are too few to conclude on this numbers. The extra loading because of the precipitation (if 
there were any) were insignificant, and there exists methods of loading dFdC into liposomes  that have 
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shown far better loading than this (Brandl and Massing 2003; Gravem 2006).  
Second and third pare of parallels 
I made two new batches of liposomes using the same procedure as last time. But one of the liposome-
batches I made with an outer pH of 7. This was to compare with the ones with about pH 4 outer pH. It 
was made in the same way as the other samples, but the dFdC that were added were in an ammonium 
phosphate (dibasic) solution that had been pH-adjusted to 7. The reason why I made one sample with a 
pH of 7 was to see if "reverse loading" could bee the cause of the low loading-efficiency. The pH in the 
other batch of liposomes was measured to a pH of 4.2.  
The PCS-results of the two batches did not differ significantly from the first pare of parallels or each 
others, and I considered them to be ok (see below). 
Table 37: PCS-results, liposomes with outer pH 4 
  
Channel width 53  
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 119.2 113.3 72.2 72.8 60 59.3 53.8 53.4
Variance (P.I) 0.607 0.676 1.024 1.086 1.107 1.126 0.852 0.834
Chi squared 224.741 422.231 3.118 9.462 0.713 0.964 1.060 1.473
Table 38: PCS-results, liposomes with outer pH of 7 
  
Channel width 48  
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 94.3 95.7 69 68.6 59.2 60.6 52.8 56.2
Variance (P.I) 0.610 76.600 0.918 0.953 0.960 0.902 0.755 0.671
Chi squared 174.070 0.640 2.126 4.479 0.733 0.876 0.991 1.181
 
Both batches were divided into two parallels. For the pH 7 -samples (samples with outer phase of pH 7) 
one sample from each parallel were taken out after step 1 (first heating), and one sample from parallel 1 
after step 5 (3rd heating). From the pH 4-samples samples were taken after step 1 (1st heating), step 3 
(2nd heating), one sample of parallel 1 after step 4 (2nd cooling, should not be any differences here), and 
after step 5 (3rd heating). The results can be seen in the table below: 
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Table 39: Loading efficiencies of dFdC into liposomes. 
 pH 4 samples pH 7 samples pH 4 samples 
Sample Step 1, #1 Step 1, # 2 Step 1 # 3 Step 1, #4 Step 3, # 1 Step 3, # 2 
Loading % 4% 5% 3% 5% 4% 7% 
       
       
 
pH 4 
sample pH 4 samples pH 7 sample   
Sample Step 4, # 1 Step 5, #1 Step 5, #2 Step 5, # 3   
Loading % 6% 6% 8% 4%   
In accordance with big variations between the parallels we can only assume that there is a slight 
tendency to increased loading of dFdC from step 1 to step 5. 
Discussion 
All in all the loading efficiencies were too low, and did not increase significantly either. Also the 
loading-speed is expected to decrease after each cycle. This is because only a certain % of the dFdC 
inside the liposomes will precipitate, so that there is always an amount of non precipitated dFdC in the 
inside of the liposomes. This amount will maximally be the same amount as of passive loading, in this 
case 5%. Since the ratio between the 20% of the inside dFdC that is not precipitated and the 5% of 
dFdC that will passively load is 4, it means that only 80% / 4 = 20 % of the total amount of dFdC in the 
solution could precipitate inside the liposomes. Hence the maximum theoretical loading in this 
experiment, after infinite cycles of heating/cooling in an ideal world where none of the precipitated 
dFdC would dissolve again upon heating, would be 25%. 
There is several ways this experiment could have been changed to improve loading. It may seem like the 
precipitation of dFdC is increasing with increasing concentrations of dFdC. By increasing the 
concentration of dFdC to in the solution at loading it is a possibility that we could have increased the 
loading-efficiency. E.g. 90% loading would have given a theoretical loading of 45%.  
Diluting the liposomes less would also probably have increased the loading efficiency. One of the great 
benefits with this method of loading liposomes is that there is now need for removing any outer 
substances by size exclusion chromatography, thereby avoid a big dilution step. Though a certain 
dilution of the liposomes is probably needed because of viscosity-reduction and the adding of the 
gemcitabine (if dFdC were mixed directly in the dry powder of the VPGs it would be hard to control 




In this project I have investigated the possibility of loading gemcitabine into liposomes by precipitation. 
We demonstrated that favorable conditions for making gemcitabine precipitate is a combination of high 
pH (< 6), a high gemcitabine concentration, and low temperatures. Our hypothesis that this 
precipitation was a result of complex-forming of gemcitabine and a salt can therefore probably be 
discarded. 
Attempts trying to load gemcitabine into liposomes using a pH of 7 inside the liposomes and an external 
pH of 4, followed by heating and cooling cycles lead to low encapsulation efficiencies (< 8%) and 
inconclusive results of whether the method gave any increase in loading compared to passive loading. 
Active loading via an ammonium sulphate gradient as described by (Gravem 2006) is based on the 
principle of an acidic pH inside the liposomes while having a more neutral external pH. Since the pH-
conditions required for precipitation is the direct opposite to condition required for active loading these 
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9.1 Appendix 1 
Results from 2nd set of experiments (loading of dFdC via an ammonium sulphate 
gradient, followed by separate detection of dFdC and cholesterol) 
Here are the results from the 2nd set of experiments. Measured concentrations means concentration 
values obtained from comparing the aria under the curve (AUC) to a standard curve. The 
concentrations marked with "~" are manually compared with the standard curve, thereby making them 
less accurate (while the other concentrations are calculated by the computer). 
Experiment 1 
Table 40: dFdC-values from the HPLC. 
Sample Loaded 1 Laded 2 Loaded 3 Loaded 4 
Control 
sample 
AUC dFdC 0 0 0 0 255168 
Theoretical 
concentration 3630 ng/ml 3630 ng/ml 3630 ng/ml 3630 ng/ml 5446 ng/ml 
Measured 
concentration 0 0 0 0 ~4000 ng/ml 
      
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4  
AUC 1712185 1742560 1699695 1726731  
Theoretical 
concentration 4.39 4.39 4.39 4.39  
Measured 





Table 41: Cholesterol values from the HPLC.  
  100% #1 100 % # 2 100% #3 100% #4 
Theoretical 
concentration 236 µg/mL 239 µg/mL 267 µg/mL 247 µg/mL
AUC 383881   (3612471)   458178   515685   
Measured 
concentration 216.59 µg/mL (2027.34) µg/mL 258.259 µg/mL 290.512 µg/mL
         
  Loaded 1 Loaded 2 Loaded 3 Loaded 4 
Theoretical 
concentration 34 µg/ml 34 µg/ml 38 µg/ml 35 µg/ml 
AUC 76559  65494  70248   86508   
Measured 
concentration 44 µg/ml 38 µg/ml 41 µg/ml 50 µg/ml 
 
Table 42: PCS-results 
    
Channel width 33 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 90 80 61 61 61 65 90 100
Variance (P.I) 0.381 0.436 0.5 0.5 0.5 0.4 0.3 0.3
Chi squared 5.713 15.762 2.4 2.57 0.5 0.6 0.7 0.8
 
Experiment 2 
Table 43: dFdC-values from the HPLC. 
Sample Loaded 1 Loaded 2 Loaded 3 Loaded 4 
Control 
sample 
AUC 0 0 0 0 0 
Theoretical 
concentration 6225 ng/ml 6225 ng/ml 6225 ng/ml 6225 ng/ml 6225 ng/ml 
Measured 
concentration 0 0 0 0 0 
      
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4 
100 % 
control  
AUC 511363 492469 479703 467553 475409 
Theoretical 
















Table 44: Cholesterol values from the HPLC. 
Sample Loaded 1 Loaded 2 Loaded 3 Loaded 4 
AUC 286659 234288 252422 303768
Theoretical 
concentration 137 µg/ml 132 µg/ml 135 µg/ml 144 µg/ml
Measured 
concentration ~600 µg/ml ~520 µg/ml ~550 µg/ml ~600 µg/ml
     
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4 
AUC 245843 241763 261774 247540
Theoretical 
concentration 137 µg/ml 132 µg/ml 135 µg/ml 144 µg/ml
Measured 
concentration ~550 µg/ml ~550 µg/ml ~550 µg/ml ~550 µg/ml
 
Table 45: PCS-results 
    
Channel width 30 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 98.1 94.9 80.5 80.5 75.1 76 72.9 81.4
Variance (P.I) 0.334 0.343 0.392 0.394 0.404 0.407 0.404 0.368
Chi squared 4.59 8.291 0.539 0.862 0.497 0.638 1.089 1.126
 
Experiment 3 
Table 46: dFdC-values from the HPLC 
Sample Loaded 1 Loaded 4 Control sample 
AUC 190501 237838 209705
Theoretical 
concentration 4150 ng/ml 4150 ng/ml 6225 ng/ml
Measured 






Table 47: dFdC-values from the HPLC 
Sample Loaded 1 Loaded 2 Loaded 3 Loaded 4 
Control 
sample 
AUC 0 0 0 0 0 
Theoretical 
concentration 6000 ng/ml 6000 ng/ml 6000 ng/ml 6000 ng/ml 6000 ng/ml 
Measured 
concentration 0 0 0 0 0 
      
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4 
100 % 
control 
AUC 483855 486480 480244 483502 325943 
Theoretical 
concentration 6000 ng/ml 6000 ng/ml 6000 ng/ml 6000 ng/ml 6000 ng/ml 
Measured 
concentration 6319 ng/ml 6353 ng/ml 6273 ng/ml 6315 ng/ml 4294 ng/ml 
 
Table 48: Cholesterol values from the HPLC 
Sample Loaded 1 Loaded 2 Loaded 3 Loaded 4 
AUC 133179 101205 112854 187995 
Theoretical 
concentration 106 µg/ml 121 µg/ml 107 µg/ml 117 µg/ml 
Measured 
concentration 99 µg/ml 84 µg/ml 90 µg/ml 124 µg/ml 
     
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4 
AUC 131108 140806 114854 152269 
Theoretical 
concentration 118 µg/ml 134 µg/ml 119 µg/ml 131 µg/ml 
Measured 






Table 49: dFdC results from HPLC, Glucose used as hydration media for the VPGs 
 Glucose used to eluate the Water used to eluate the  














AUC 0 0 0 0 0 0
Theoretical 
concentration 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 
Measured 
concentration 0 0 0 0 0 0
       
Sample 100 % # 1 100 % # 2 100 % # 3 100 % # 4   
AUC 244069 244945 233312 232276   
Theoretical 
concentration 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml   
Measured 
concentration 3378.7 3387.6 3230 3215.96   
 
Table 50: dFdC results from HPLC, PBP-solution used as hydration media for the VPG's 
 PDP-solution used to eluate the  Water used to eluate the  












AUC 109424 78538 48978 0 0  
Theoretical 
concentration 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml  
Measured 
concentration 1551.8 1133.4 733 0 0  
       
Sample 100% #1 #100% 2 100% #3 100% #4   
AUC 247205 237658 261445 260750   
Theoretical 
concentration 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml 6,0 µg/ml   
Measured 





Table 51: PCS-results, 50g/L glucose used as hydration media for the VPG's 
    
Channel width 45 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 139.6 137.8 104.8 101.1 100.4 104.3 151.7 152
Variance (P.I) 0.398 0.394 0.477 0.489 0.475 0.462 0.319 0.316
Chi squared 25.203 59.045 0.256 0.465 0.351 0.328 0.803 0.759
 
Table 52: PCS-results, 50mM PDP-solution used as hydration media for the VPG's 
    
Channel width 99 
(auto) Channel width 20 Channel width 10 Channel width 5 
Mean diameter 
(nm) 375.3 433.6 91.7 79.4 79.2 73.5 67.5 59.2
Variance (P.I) 0.45 0.391 1.219 1.188 1.173 1.192 0.887 1.038
Chi squared 520.214 890.151 0.565 1.609 0.348 0.471 0.55 0.712
 
Calculations of dilution of the liposomes and the inner aquas phase 
These calculations are based on the assumption that the start distribution between outside and inside 
water content of the VPGs are 60% /40%. In the further dilution of the VPGs, a step to lower the 
viscosity, the liposomes were diluted 1/3. They are then diluted 1/2 prior to removal of outer 
ammonium sulphate by size exclusion chromatography. In the process of size exclusion chromatography 
the liposomes were on average diluted 1/7. At loading there was a small dilution step of 200/225. The 
end result is that the concentration in percent of the total amount of the total water content being inside 
the liposomes is as follows: 
4/10 (start amount of water phase inside the liposomes) * 1/3 (dilution of VPGs) * 1/2 (dilution prior 
to size exclusion chromatography) * 1/7 (dilution on the size exclusion chromatography column) * 
200/225 * 100% = 0.847%.  




Calculations of molar concentration and quantity of dFdC at loading 
In the 2nd set of experiments I used a concentration of 0.111mg/mL dFdC upon loading. dFdC has a 
molar mass of  263.199mg/mmol. The molar concentration of dFdC is then: 
0.111mg/mL / 263.199mg/mmol = 4.2173*10-4 mmol/mL = 0.4217mM. 
The total volume that was used in the experiments was 2250μL, or 2.25*10^-3 L. The number of mol 
of dFdC in this solution is then 2.25*10^-3 L * 0.4217mM = 9.488*10^-4 mmol = 0.9488 μmol. 
The amount expected to load passively, 0.847%, is 0.847% * 0.9488 μmol = 8.036*10^-3 μmol. 
Calculations of amount of charged acredine orange inside the liposomes 
Acredine orange has a pKa of 10.45. If we assume that the pH inside the liposomes is 3 (due to the 


















So there is about 28183829 times as much charged AO (AO+) as there is non-charged AO, meaning 
close to 100% of the AO inside the liposomes will be charged. 
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Calculations of amount of charged dFdC inside the liposomes 
Gemcitabine has a pKa of 3.58. Assuming the pH inside the liposomes is 3 (due to the ammonium 

















So there is 3.8 times as much dFdC+ as there is non-charged dFdC at pH 3, meaning 79% is charged. 
Theoretical amounts of ammonium sulphate within the liposomes 
In the solution of VPGs and liposomes there is 650μL 120mM ammonium sulphate and 350mg VPGs. 
Counting all as one volume the real concentration of ammonium sulphate is 650μL * 120mM / 1000μL 
= 78mM. If we assume 40% of all water-content in the VPG's to be inside the liposomes at the start, 
we can use the calculated expected water-amount of water in the liposomes as calculated four sections 
above. The volume of water inside the liposomes if the liposomes contain 0.847 % of the total water-
volume is: 
2250μL * 0.847% = 19.06μL = 1.906*10^-5 L. 
From this we can calculate the theoretical quantity of ammonium sulphate: 
78 mM * 1.906*10^-5 L = 0.001486 mmol = 1.486 μmol. 
Calculations of maximum theoretical loading 
In the following calculation I pretend that the pH inside the liposomes is stable, and thereby also the 
charged amount of dFdC no mater how much dFdC that are loaded:  
We can assume that passive loading with the concentrations we use gives a loading of about 0.847%. If 
pH inside the liposomes is 3 then 79% of the dFdC inside the liposomes will be charged, according to 
the calculations above. Taken the passive loading into consideration this means that 0.669 % of the total 
[dFdC] (outside and inside the liposomes) is now charged (ignoring the fact that 0.02% of the dFdC 
outside the liposomes also will be charged). 0.178 % of total [dFdC] will be inside the liposomes but 
not charged. Because of passive diffusion this amount will rice to 0.847% (the theoretical amount that 
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will passively load), meaning we get 0.669% more dFdC inside the liposomes. We now got 1.338 % of 
the total concentration of dFdC inside the liposomes. 79% of this, 1.057% of the total [dFdC], will be 
charged. This leaves 0.281% of the dFdC inside the liposome not charged. This amount will then again 
rice to 0.847%, adding 0.566% new dFdC inside the liposomes. Now we got 1.904% of the total 
amount of all dFdC inside the liposomes, and so on. The number of new dFdC coming into the 
liposomes after each "cycle" is decreasing. So after a while the loading will stabilize with non charged 
dFdC being 0.847% of the total amount of dFdC, and being 31% of the total dFdC inside the 
liposomes. The total percentage of dFdC inside the liposomes would then be 0.847%/21% * 100% = 
4.03% loading. 
In the solutions used in our experiments the total dFdC in the solution was 0.9488 μmol. The amount 
of dFdC in μmol that would maximum have entered the liposomes according to our model is therefore 
0.0398μmol. This would have been possible, the total amount of ammonium sulphate inside the 
liposomes is expected to be 1.486 μmol. 
Calculations of the isotonicity of solutions 
Ammonium sulphate is isotonic at 1.68% (w/v), (16.8 mg/ml). It's molar weight is 142.14mg/mmol. 







Potassium dihydrogen phosphate is isotonic at 2.18% (w/v), (21.8 mg/ml). It's molar weight is 







All the isotonicity percentages are taken from the Merk-index. 
 
  101
9.2 Appendix 2 
Calculations of the isotonicity ammonium phosphate (dibasic) 
Ammonium phosphate (dibasic) is isotonic at 1.76% (w/v), (17.6 mg/ml). It's molar weight is 
136.06mg/mmol. Calculating the molar concentration of this gives us: 
mMmlmmol
mmolmg
mlmg 27.133/13327.0
/06.132
/6.17
==  
 
 
 
 
 
 
 
